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Discovering new viral-host cell interactions is fundamental to the discovery of novel methods to target 
viral infections. Due to the parasitic nature in which virus’s replicate, it is important to identify the exact 
mechanisms by which they interact and hijack host cell protein machinery. A novel interaction between a 
human cellular protein and a viral proton channel protein was identified through a yeast two-hybrid 
screen. This interaction is between viral protein M2 and a protein phosphatase regulatory subunit. 
Protein phosphatases remove phosphate groups from proteins; this usually results in deactivation of 
proteins. Activation and deactivation of proteins by phosphorylation is fundamental for signalling 
cascades. The regulatory subunit PP4R3α (SMEK1) regulates protein phosphatase 4 (PP4), which is a 
complex formed with other subunits (PP4R2 and PP4c). PP4 has many functions within human cells. 
PP4 has been identified to be involved in the type-1 interferon signalling cascade, which plays a crucial 
role in viral recognition and immune response stimulation. The hypothesis was that this interaction has 
important implications for the host and the virus. The interaction between SMEK1 and M2 was confirmed 
by co-immunoprecipitation. It was also found that influenza A virus (IAV) infection caused an increase in 
PP4c expression in A549 lung epithelial cells. By understanding the way in which IAV M2 interacts with 
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1.1 Influenza A Virus 
1.1.1 Epidemiology 
The Influenza A virus (IAV) presents a real threat to world health. Viruses of H1N1 and H3N2 subtypes 
cause seasonal epidemics in humans. Symptoms are usually mild but can be severe in populations at 
risk (elderly, young children and pregnant women). 200,000 to 500,000 people die every year from these 
respiratory infections (WHO, 2015). The threat is due to the emergence of highly pathogenic strains from 
the animal reservoir as well as the ability of influenza viruses to mutate and recombine.  
Adaption of IAV to new hosts depends on the sialic acid (SA) receptors on the surface of host cells that 
haemagglutinin (HA) binds to (Zeng et al., 2013; Couceiro et al., 1993; Baum and Paulson, 1990). There 
are two types of SA receptors, human influenza strains prefer α2,6-linked SA, however avian influenza 
prefers α2,3-linked SA. Tropism and infectivity of influenza depends on these two receptors. α2,6-linked 
SA are found on epithelial cells including ciliated cells in the upper respiratory tract, whereas α2,3-linked 
SA are primarily found on non-ciliated bronchial cells and alveolar type 2 cells in the lower respiratory 
tract (Zeng et al., 2013; Couceiro et al., 1993; Baum and Paulson, 1990). This explains why seasonal 
human influenza primarily infects the upper respiratory tract, whereas pandemic highly pathogenic 
strains that have recombined from avian influenza are found to infect the lower respiratory tract. 
1.1.2 Structure/Genome 
IAV are enveloped, negative strand RNA Orthomyxiviridae viruses, which are composed of a host-
derived membrane. The membrane contains 3 viral proteins: haemagglutinin (HA), neuraminidase (NA) 
and small amounts of matrix proton channel protein (M2). HA and NA are used to classify different 
strains of IAV (Muller et al., 2012; Nayak et al., 2009). The viral genome consists of eight segments of 
negative sense RNA, which are replicated in the host nucleus alongside host DNA (Figure 1) (Roberts et 
al., 2013; Nayak et al., 2009; Chen et al., 2008a). 
The genome encodes for up to 12 proteins: the surface proteins HA and NA, matrix protein 1 (M1), 
matrix protein 2 proton channel (M2), nucleoprotein (NP), non-structural protein 1 (NS1), nuclear export 
protein (NEP), polymerase acid protein (PA), polymerase basic proteins 1 and 2 (PB1 and PB2), NS1 
and PB1-F2 which are only found during viral replicaition (Muller et al., 2012). PB1, PB2 and PA form 
RNA-dependent RNA polymerase (RdRp), in combination with NP and vRNA form viral 
ribonucleoprotein (vRNP) (Muller et al., 2012). The structure of IAV, including the 8 viral RNA segments 
is shown in Figure 1. 
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Figure 1. Schematic diagram of IAV structure. Shown are membrane proteins HA and NA, M2 spanning 
the viral membrane, M1 on the interior of the membrane. PA, PB1 and PB2 associated with the 8 
labelled segments of viral RNA (Horimoto and Kawaoka, 2005). 
1.1.3 Life cycle 
The viral lifecycle depends on utilisation of host cell protein machinery to reproduce and generate 
progeny virus. The influenza lifecycle consists of 5 main events: entry into the host cell; vRNP entry into 
the host nucleus; viral genome transcription and replication; vRNP export from the nucleus; virion 
assembly; and budding at the host cell plasma membrane (Figure 2) (Samji, 2009). 
1.1.3.1 Entry into host cell 
IAV entry into cells is dependent on virion shape (circular or filamentous).This is via clathrin-mediated 
endocytosis or macropinocytosis; viral HA proteins bind to terminal sialic acid moieties on receptors on 
the host cell membrane (Muller et al., 2012; de Vries et al., 2011; Eierhoff et al., 2010). Viral entry is 
determined by the host processing proteases of HA, which activates membrane fusion activity (Kido et 
al., 2008). HA-sialic acid binding stimulates reorganisation of the plasma membrane, which leads to lipid 
raft clustering, that then acts as a signalling platform for viral internalisation (Muller et al., 2012; Eierhoff 
et al., 2010). The epidermal growth factor receptor (EGFR) cascade is also stimulated by HA-sialic acid 
binding; this promotes endocytosis of viral particles (Muller et al., 2012). Eierhoff et al., (2010) presented 
data that suggests that when IAV binds to sialic acid, viral uptake is promoted by IAV clustering; this 
allows activation of EGFR and of other receptor tyrosine kinases. EGFR stimulation alone is not 
sufficient to induce viral uptake. Evidence suggests that this process also requires the activation of cell 
signals such as phosphatidylinositol-3 kinase (PI3K), protein kinase C (PKC) and extracellular signal-
regulated kinase (ERK) (Eierhoff et al., 2010). Activation of PKC occurs at the point at which HA binds to 
the cell membrane; PKC isoform βII then sorts the virus into late endosomes (Eierhoff et al., 2010). 
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Spherical viral particles are sorted into clathrin-coated pits forming at attachment sites, for viral 
endocytosis (de Vries et al., 2011). It has been shown that there are alternative pathways for viral 
entrance to the host cell through non-coated pits by micropinocytosis (Muller et al., 2012; de Vries et al., 
2011). It was suggested that filamentous virions use macropinocytosis as, due to their larger size, they 
are unable to fit into the clathrin coated pits that spherical virions induce through the binding of tyrosine 
kinases receptors (Rossman and Lamb, 2011).  
Seasonal IAV targets upper respiratory tract epithelial cells for infection; highly pathogenic strains target 
the lower respiratory tract due to differential tropism of viral strains (Zeng et al., 2013; Couceiro et al., 
1993; Baum and Paulson, 1990). These cells are coated with a thick layer of mucous, which consists of 
small particles and glycoproteins (de Vries et al., 2011). Environment can also affect the mode of entry 
into host cells used by IAV; it is most likely that virion shape is the most important deciding factor (de 
Vries et al., 2011). 
1.1.3.2 Acidification in endocytosis and entry into host nucleus, 
Once inside the cell the virus is exposed to low pH (5.5-5.0), which changes the conformation of viral 
HA. This allows endosomal membrane binding for release of the capsid into the cytoplasm (Banerjee et 
al., 2013).  M2 possess a pH-activated channel that can selectively gate protons into the virion during 
the uncoating process (Roberts et al., 2013; Sun et al., 2010). The M2 protein promotes viral interior 
acidification that facilitates viral disassembly (Wharton et al., 1994).  
Acidification of the viral interior causes M1 and vRNP separate from each other. vRNP localises to and 
is imported into the nucleus whilst M1 is released into the cytosol (Banerjee et al., 2013; Perez et al., 
2010). Host cellular factor RanBP5 has been found to interact with the vRNP protein PB1 or PA-PB1 
heterodimer to aid PA-PB1 dimer enter the host nucleus to form PA-PB1-PB2 complex (Li et al., 2011). 
1.1.3.3 Transcription and replication 
The viral ribonucleoprotein (vRNP) complex is responsible for the transcription and replication of the viral 
genome (Perez et al., 2010). This complex consists of the 8 RNA segments of the viral genome as well 
as RNA-dependent RNA polymerase, which consist of 3 subunits (PA, PB1 and PB2). Each of the 
subunits has very important roles within the polymerase complex (Perez et al., 2010). The promoter is 
one of the non-coding regions of the viral RNA that forms a corkscrew-like structure recognised by RdRp 
(Li et al., 2011; Perez et al., 2010). Viral polymerase uses host RNA oligonucleotides as primers for viral 
RNA transcription by seizing host mRNA, cleaving around 10-13 bases downstream of the 5’ cap with 
PA for use by PB1 as a viral primer (Li et al., 2011; Perez et al., 2010). RdRp associates with the non-
coding region of the gene, initiating transcription at the first 3’ cytosine (Perez et al., 2010). Transcription 
termination occurs at a sequence of 5-7 uridines 15-17 nucleotides upstream from the 5’ end of the 
vRNA templates (Li et al., 2011). 
Replication requires the synthesis of a positive sense RNA copy of the genome as a template to produce 
progeny vRNA (Li et al., 2011). Hsp90 interacts with PB2/ PB1-PB2 dimer to excite vRNA polymerase 
activity and promote entry into the nucleus to form the viral polymerase complex (Li et al., 2011). 
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1.1.3.4 Export from the nucleus 
IAV RNA associates with nucleotide proteins and RNA polymerase subunits to form the viral 
ribonucleocapsid (vRNP); this exits via nuclear pores and is transported to the plasma membrane on 
host microtubules (Roberts et al., 2013). vRNA could piggyback onto Rab11 positive vesicles for 
transport to the plasma membrane, as monesin treatment during infection inhibits vRNA movement from 
the ER (Amorim et al., 2011). It is hypothesised that Microtubules are used for long-distance transport of 
RNPs; a degree of functional redundancy would explain minor effect of cytoskeletal positions on viral 
titre (Amorim et al., 2011). Cytoplasmic trafficking of IAV genome involves Rab11. It is hypothesised that 
there is a direct interaction between the RNA polymerase complex protein PB2 and Rab11, although 
there could be Rab11 related proteins involved that bridge the interaction (Amorim et al., 2011; 
Rossman and Lamb, 2011). M1, Rab11 and Rab11-interacting proteins are also required for formation of 
filamentous virions (Roberts et al., 2013). 
1.1.3.5 Assembly and budding 
At the plasma membrane, the vRNP associates with matrix proteins M1, along with M2, HA and NA 
where it forms the budding virion (Roberts et al., 2013). M1 forms a matrix protein layer that links the 
outer membrane to the inner helical vRNP (Rossman and Lamb, 2011; Nayak et al., 2009). M1 is 
recruited to the cytoplasmic tails of HA and NA underneath the plasma membrane. Here it associates 
with the lipid raft and recruits M2 to the plasma membrane to sites of viral budding (Gorai et al., 2012; 
Rossman and Lamb, 2011). M2 modifies M1, which enables it to polymerise and create the inner 
structure of the budding virion (Gorai et al., 2012; Rossman and Lamb, 2011). M1 is recruited to lipid raft 
domains by HA cytoplasmic domains and NA residue (Chen et al., 2008a). M1 recruits M2 to the 
periphery of lipid rafts where it is mostly excluded from the budding virion (Roberts et al., 2013). This 
stabilises the budding site in the initial stages to allow polymerisation of the matrix protein for 
filamentous virion formation by elongation of the matrix protein (Gorai et al., 2012; Rossman and Lamb, 
2011). 
The M1 binding region on M2 overlaps with its supposed cholesterol-binding domain. This could explain 
why M2 is excluded from the cholesterol rich lipid-rafts that M1 is recuited to. M2 is therefore recruited to 
the budding zone via binding to M1, causing exclusion from budding zone. M2 also contains an effector 
domain for effective virion formation and proper morphology (McCown and Pekosz, 2006). M2 mediated 
packaging of budding virions is facilitated by binding to the M1 proteins in the vRNP complex, then M1 
interacting with other M2 cytoplasmic tails for efficient genome packaging (Chen et al., 2008a; McCown 
and Pekosz, 2006). 
M2 is only found to be recruited around the edges of the HA and NA rich lipid raft domains due to M1 
cholesterol binding domain overlap with M2 binding domain (Chen et al., 2008a). It is possible that IAV 
may use its genome to drive forward the interactions required for virion formation at budding sites 






















Figure 2. IAV lifecycle. Virus entry: Viral protein HA binds to host receptor molecules at the plasma 
membrane stimulating IAV entry by endocytosis. 1: Endosomal acidification leads to conformational 
changes in HA; this facilitates virion and endosomal membrane fusion, which allows the viral genome 
access to the cytoplasm. 2: M2 promotes virion interior acidification, which causes M1 to dissociate from 
the viral genome; this releases vRNPs to travel to the nucleus via nuclear pore complex. 3:  Primary 
transcription of viral proteins occurs and viral mRNA is exported to the cytoplasm where cellular 
ribosomes translate viral proteins. 4:  Viral proteins are transported to the plasma membrane; viral 
genome replication occurs. 5:  vRNP are exported to the cytoplasm with the help of M1 and NEP. 6:  
vRNPs are trafficked to the plasma membrane via Rab11. 7:  vRNPs are incorporated into the assembly 
virion progeny (Eisfeld, Neumann and Kawaoka, 2015).  
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1.1.4 Proton channel viral protein M2 
IAV M2 protein plays a crucial role in IAV life cycle (Figure 2). M2 is a protein of 97 amino-acids, with a 
24-residue extracellular domain, 20-residue transmembrane domain and 53-amino-acid cytosolic tail 
(CT) (Rossman and Lamb, 2011; Sun et al., 2010). M2 forms a proton channel, which is activated at 
acidic pH (Figure 3). M2 is important (i) for virus uncoating at early stages of cell infection through 
acidification of the interior of viral particles after endocytosis by target cells, (ii) for transporting of HA at 
the cell surface at later stages; when M2 proton channel activity enables de-acidification of the trans-
Golgi lumen to prevent premature activation of HA, and finally (iii) for budding and releasing of nascent 
virions at the cell surface (Roberts et al., 2013; Sun et al., 2010).   
The amphipathic helix residues 46-62 of the cytosolic tail are highly important in producing infectious 
virions. They aid the packaging of viral RNA, and are involved in the efficiency of budding (Rossman and 
Lamb, 2011; McCown and Pekosz, 2006). As a multifunctional matrix protein, M2 has a role in 
determining where on the plasma membrane virion assembly takes place and where it associates with 
the membrane as a homotetramer (Figure 3) (Roberts et al., 2013; Sun et al., 2010). M2, specifically its 
amphipathic helix, induces negative membrane curvature; this may stabilise the budding site which 
enables filament formation (Rossman and Lamb, 2011). The M2 amphipathic helix is involved in 
localisation to the host membrane, thus having a role in budding and scission (Roberts et al., 2013). The 
hydrophobic face of the amphipathic helix contains residues that insert into the plasma membrane. This 
secures it and allows polar residues to induce membrane curvature (Roberts et al., 2013). The 
amphipathic helix of M2 has only a weak interaction with the viral protein HA as seen in mutated M2 
proteins. Therefore, other interactions are required for full localisation of M2 to the viral budzone at a 
lipid raft (Roberts et al., 2013). 
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Figure 3. This figure shows the M2 domains and structural motifs. Panel A shows the M2 protein with 
CRAC motif, Ecto (ectodomain), TM (transmembrane) domain and amphipathic helix of cytoplasmic tail 
of M2 sequence identified. B shows the helical wheel plot of the amphipathic helix, generated by 
Rossman et al, (2010) at http://heliquest.ipmc.cnrs.fr. Hydrophobic residues are in grey and hydrophilic 




1.1.5 Immunological anti-viral response 
1.1.5.1 Initiation of response 
Recognition of pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors 
(PRRs) initiates the host immune response (Yoo et al., 2013; Holt et al., 2008). This causes a cascade 
of events that leads to the stimulation of the inflammasome, which is an innate intracellular protein 
complex that has a key role in innate and adaptive immune response to viral infection (Yoo et al., 2013; 
Takeuchi and Akira, 2009). 
1.1.5.1.1 Type 1 Interferons (IFN-1) 
Type 1 interferons are activated following PRR recognition of pathogen components (Yoo et al., 2013). 
IFN-1 induce transcription of many essential infection resistance genes. These include components of 
the innate and adaptive immunity, such as antigen presentation and cytokine production which activate 
T cells, B cells and natural killer (NK) cells (Yoo et al., 2013). IRF3 transcription factor is phosphorylated 
and activated by viral infection and by dsRNA (Killip et al., 2014). IRF3 then travels to the nucleus to 
switch on IFN expression (amongst other genes), IFN is secreted and diffuses out of the cell (Killip et al., 
2014). This creates an anti-viral environment in neighbouring cells (Yoo et al., 2013). IFN-1 then binds to 
receptors on neighbouring cells to induce formation of ribonuclease (RNase), protein kinase, and 2-5A 
synthetase (the last two are also stimulated by dsRNA). 2-5A synthetase then activates ribonuclease to 
degrade RNA (Killip et al., 2014). Protein kinases phosphorylate and inactivates protein chain initiation 
factors; this prevents the formation of proteins (Killip et al., 2014). The combination of RNA degradation 









1.2. Protein Phosphatases  
Protein phosphatases (PSPs) act in parallel to protein kinases. Protein kinases add phosphate groups to 
proteins from ATP through hydrolysis of ATP to ADP and a phosphate group; protein phosphatases act 
to remove these phosphate groups (McAvoy and Nairn, 2010).	There are around 30 PSPs that are 
divided into 3 main groups, the phosphoprotein phosphatases (PPPs), metal dependent phosphatases 
(PPMs) and aspartate-based phosphatases (FCP/SCPs) (Shi, 2009). PSPs form holoenzymes 
composed of a catalytic and a regulatory subunit (Shi, 2009). There are limited numbers of 
phosphatases and a wide range of substrates; therefore, there are many regulatory subunits that confer 
substrate specificity to the holoenzyme (Shi, 2009). The addition of phosphate groups to proteins 
activates them. Serine, threonine and tyrosine are the amino acids most commonly phosphorylated. 
Within the PPP group of phosphatases there are two major Ser, Thr and Tyr phosphatase groups; these 
are structurally and mechanistically different from each other (McAvoy and Nairn, 2010). 
The two groups of serine/threonine phosphatases, (PPM), include PP2A and PPP. The PPP subfamily 
includes phosphatases PP1 and PP2A. The PP2A subfamily of phosphatases includes PP2A, PP4 and 
PP6, which are more closely related by sequence than other phosphatases (Wang et al., 2008). The 
PP2A family, composed of PP4c (catalytic subunit) and R2/R3 (regulatory subunits), forms the 
holoenzyme shown in Figure 4 (Gingras et al., 2005).  
1.2.1 Human PP4 
1.2.1.1 The PP4 complex 
The PP4 (protein serine/threonine phosphatase 4) core complex contains a catalytic unit (C) and a 
scaffold subunit (A). The subunit interacts with a wide range of other regulatory subunits and proteins 
that target the AC core dimer to specific substrates and subcellular locations (Wang et al., 2008). PP4 
AC core dimer (PP4c) forms 3 mutually exclusive complexes, PP4c-PP4R1, PP4c-PP4R2-PP4R3α 
(SMEK1) and PP4c-PP4R2-PP4R3β (Wang et al., 2008). The PP4c-PP4R2-PP4R3α complex is shown 
in Figure 4. PP4R3α (ortholog of SMEK1 in Dictyostelium and FALAFEL in Drosophila) is a subunit of 
PP4 as are PP4R3β and SMEK2. PP4 holoenzyme is implicated in the following cellular processes: 
microtubule growth and organization (Toyo-oka et al., 2008); apoptosis (Wolff et al., 2006; 
Mihindukulasuriya et al., 2004; Mourtada-Maarabouni et al., 2003); TNF signaling (Mihindukulasuriya et 
al., 2004); and pre-T-cell receptor signaling (Shui, Hu and Tan, 2007). siRNA knockdown of PP4 results 
in embryonic lethality in mice (Wang et al., 2008). This means the functions of PP4 are probably 
essential for mammalian development.  
1.2.1.1.1 T cell response 
It has been shown that PP4 plays an essential role in thymocyte development and pre-T-cell receptor 
signalling (Shui, Hu and Tan, 2007). By deleting PP4 in the T-cell lineage Shui et al. demonstrated that 
PP4 has an essential role in thymocyte development and efficacy of positive selection. It was also 
shown the PP4 has a role in calcium flux and phospholipase C-ϒ-1-extracellular signal-related kinase 
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activation (Shui, Hu and Tan, 2007). It has also been noted that PP4 negatively regulates AMP-activated 
protein kinase (AMPK) (Liao et al., 2016). AMPK is an important serine/threonine kinase that regulates 
cellular metabolism through inhibiting mTOR and cell cycle progression to inhibit proliferation (Liao et al., 
2016). By inhibiting AMPK, PP4 allows T-cell proliferation and expansion through mTOR.  
1.2.1.1.2 Negative regulation of type I interferon (IFN) 
Type 1 IFN (IFN-1) has a central role in the clearance of viral infection. Its production is highly regulated 
as overexpression can lead to autoimmune disorders; thus, careful regulation is required to maintain 
homeostasis (Zhan et al., 2015). Activated TANK-binding kinase1 (TBK1) phosphorylates and thus 
activates IRF3. PP4 specifically inhibits RNA virus induced IFN-β activity by dephosphorylation of TBK1 
after infection at Ser 172, shown in Figure 5 (Zhan et al., 2015). PP4c has been found to maintain 
homeostasis of TBK1 in macrophages and dendritic cells (Zhan et al., 2015). It has been reported that 
PP4 expression is increased in pandemic H1N1 infected KY/136 lung bronchial epithelial cells (Zhan et 
al., 2015). Further investigation with other viral strains and cell lines would be beneficial to clarify the role 
of PP4 in anti-viral response.  
1.2.1.1.3 Inhibition of NFκB activation 
There has been evidence of interactions between PP4c and signalling pathways involving NFκB 
(Brechmann et al., 2012; Martin-Granados et al., 2008). Dephosphorylation by PP2A at Ser (exact Ser 
residue unknown) inhibits NFκB p65 subunit, whereas dephosphorylation by PP4c of Thr 435 activates 
NFκB (Martin-Granados et al., 2008; Yeh et al., 2004). PP4 is activated by TNFa-induced Ser/Thr 
phosphorylation; TNFa is also a NFκB inducer (Yeh et al., 2004; Zhou et al., 2002). TNFa may be 
inducing through involvement with PP4c. Thr435 is the targeting residue of the interaction between 
NFκB and PP4c, residues 281:444 are the NFκB amino acids responsible for the PP4c- NFκB 
interaction (Yeh et al., 2004). SMEK1/ PP4R3α has been found to downregulate NFκB when combined 
with germacitabine, increasing apoptosis (Dong et al., 2012; Byun et al., 2012).  
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Figure 4. Hypothetical PP4 complex formation and localisation to centromere in Drosophila cells, 
SMEK1 interacts with Falafel Binding Domain of CENP-C (violet arrow). The trimeric holoenzyme of 
PP4; PP4c, R2 and R3 (Falafel in Drosophila) binds via PP4c dephosphorylation of R3 and CENP-C 
binding (red stars). PP4 activity at centromeres is important for maintaining mitotic centromere integrity 





Figure 5. Schematic diagram of the IFN pathway and interaction of PP4c based on research by Zhan et 
al. (2015). Shown is where PP4c dephosphorylates TBK1 at Ser-172, leading to TBK1 inhibition and 
downstream signalling. Without dephosphorylation IFN-regulatory factors are phosphorylated leading to 





















1.2.1.1.4 F-actin interactions 
There are potential links to F-actin interactions in cell extensions in sub-confluent regions due to 
decreased F-actin immunostaining in 70% PP4c depleted cells (Martin-Granados et al., 2008).  
1.2.1.2 PP4R1 function 
There is evidence that PP4R1 targets the PP4c holoenzyme to the IκB Kinase (IKK) complex. IKK 
activation (via phosphorylation) results in subsequent phosphorylation of inhibitory κB proteins (IκB 
proteins); these binds to and deactivate NFκB within the cytoplasm (Brechmann et al., 2012). Research 
has not demonstrated whether SMEK1 forms part of the holoenzyme with PP4 and PP4R1; that was one 
of the areas of investigation in the study by Brechmann et al (2012).  
1.2.1.4 PP4R3α and PP4R3β function 
PP4R3α (ortholog of SMEK1 in Dictyostelium and FALAFEL in Drosophila) is a subunit of PP4. The R3 
subunit (SMEK) is known to target PP4c to its substrate; SMEK1 Ran Binding Domain (RanBD) contains 
domains that bind PP4c to SMEK1 (Lyu et al., 2013). This regulates PP4c structure and function through 
centromere targeting, shown in Figure 4. The way these subunits cooperate and mediate substrate 
specificity, sub-cellular localisation and holoenzyme stability is not well understood (Lipinszki et al., 
2015). R3 orthologues are conserved throughout evolution with similar domain architecture and have 
been found in a wide variety of organisms from yeasts to humans (Lipinszki et al., 2015). The modular 
activity of its subunits regulates PP4 function. SMEK1 (PP4R3α) and SMEK2 (PP4R3β) are human 
isoforms; SMEK2 is involved in regulation of S phase. The SMEK2 complex requires R2 and R3β to 
target the PP4 complex to centrosomes (Lipinszki et al., 2015) 
SMEK1 is involved in a wide variety of activities (Table 1): suppression of MEK (Mendoza et al., 2005), 
H2AX phosphorylation and histone H3 and H4 acetylation (Lyu, Jho and Lu, 2011). In Dictyostelium 
SMEK1 function is regulated by its localisation. Nuclear localisation is important for some of PP4c 
functions following the induction of stress signals; SMEK1 translocates PP4c to the cytoplasm through 
hypothesised interactions with the EVH1 domain(Mendoza et al., 2007). Overexpression of SMEK1 
leads to increased nuclear accumulation of PP4c in Dictyostelium; however, further clarification on this is 
required (Mendoza et al., 2005). The localisation function of SMEK1 is mediated by a nuclear 
localisation signal (NLS) at the C-terminal (Figure 4) (Mendoza et al., 2007). 
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Function Targets Reference Cell Type 
Cell cycle 
progression 
Cyclin D1, cyclin 
dependent kinase 4, 
p27, centrosomes 
and mitotic spindles 










Mitosis Par3 (Lyu et al., 2013) E14 mouse 





(Lipinszki et al., 
2015) 
D.Mel-2 cells, mouse 
embryonic fibroblasts 
Centrosome 
maturation and cell 
migration 









DNA repair Histones H3 and H4, 
H2AX, HDAC1 
(Lyu, Jho and Lu, 
2011; Martin-
Granados et al., 
2008) 
Embryonic stem 
cells, HEK293 cells 




W7.2 mouse cell line 
(derived from WEHI-
105.726) 
Type 1 interferon TANK-binding kinase 
1 
(Zhan et al., 2015) C57BL/6 mice 




NFkB activation p21, p53 (Byun et al., 2012) OVCAR-3 cells 







SKOV-3 cells  
HEK293/T cells, 
W7.2 mouse cell line 
(derived from WEHI-
105.726) 
Table 1. Shown are the various cellular functions that the PP4 complex (PP4c-PP4R3α-PP4R2) is 
involved in and the targets of the PP4 complex within these processes. For reference, papers that these 
targets were identified in are included, as well as the cell types.  
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1.2.2 SMEK1 Gene and protein structure 
SMEK1 gene is found on chromosome 14, band q32.12. The gene is 53,074 bp long and composed of 
17 exons (Weizmann Institute of Science, 2015). It encodes a protein of 833 amino acids with a weight 
of 95368 Da (Weizmann Institute of Science, 2015). SMEK1 is a ubiquitous regulatory subunit of PP4C 
with 3 isoforms in humans; this associates with the structural protein PP4R2 (Lipinszki et al., 2015; 
Martin-Granados et al., 2008).  
 
1.2.3 SMEK1 functions 
1.2.3.1 Cell cycle 
SMEK1 affects cell growth inhibition through apoptosis via caspase activation, downregulation of Bcl-2 
and upregulation of Bax expression (Byun et al., 2012; Dong et al., 2012). SMEK1 addition has shown 
suppression of the cell cycle, causing G1 growth arrest through reducing expression of Cyclin D1 and 
CDK4; this is due to inhibition by p21 and p27 (a Cyclin D1 inhibitor) (Dong et al., 2012). This pathway 
has yet to be described. 85% depletion of PP4c resulted in many cells progressing slowly through G2. 
This suggested that PP4c depletion slowed progression through G2 or prevented normal mitotic 
progression (Martin-Granados et al., 2008). This was caused by interactions with centrosomes and 
mitotic spindles (Martin-Granados et al., 2008). PP4c–R2–R3 complex regulation of RhoGTPases may 
co-ordinate centrosome maturation and cell migration (Martin-Granados et al., 2008). PP4c is also 
involved in prometaphase. Depleted cells were halted at prometaphase, which further confirmed 
involvement of PP4C with mitotic spindles (Martin-Granados et al., 2008). The R3β subunit (SMEK2) is 
involved in S-phase progression, behaving like a chromatin protein that has been phosphorylated by 
Cyclin-dependent kinases (Lipinszki et al., 2015). Mitotic centromere integrity is reliant on PP4, which 
requires SMEK1 interactions to deliver the catalytic subunit. Therefore, the PP4c-R2-R3 complex 
regulates maturation of the centrosome (Figure 4) (Martin-Granados et al., 2008). 
SMEK1 was distributed in larger amounts in the nucleus in comparison to the cytoplasm during 
interphase; there was no intense staining at the centrosome. R3β was similarly distributed in larger 
amounts, but was localised to the centrosomes during mitosis (Martin-Granados et al., 2008). R3 
subunits use their influence in DNA repair pathways and the subsequent role of these repair pathways 
influence cell cycle progression (Lipinszki et al., 2015). PP4c is critical for microtubule growth and 
organisation; this is due to its interactions with regulatory proteins (Chen et al., 2008b). SMEK1 is 
essential for cytokinesis during vegetative growth, when it is localised to the cell cortex (via an EHV1 
domain). Following the initiation of development, SMEK1 translocates to the nucleus due to a NLS at the 
C terminus (Toyo-oka et al., 2008; Mendoza et al., 2005). PP4c negatively regulates cyclin dependent 
kinase 1 (CDK1) activity at the centrosome; loss of PP4c leads to unscheduled activations of CDK1 in 
interphase (Toyo-oka et al., 2008). NDEL1 is a substrate of CDK1. Phosphorylation of NDEL1 recruits 
katanin p60 to control microtubule dynamics at centrosome and facilitates microtubule remodelling 
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(Toyo-oka et al., 2008). PP4c is functionally dominant over CDK1; it may therefore be a checkpoint 
protein (Toyo-oka et al., 2008).  
1.2.3.2 Development 
In Dictyostelium SMEK1 localises to the cell cortex via its EVH1 domain at the N terminus during 
vegetative growth, where it is required for proper cytokinesis. There is a 72% similarity between the 
EVH1 domain in Dictyostelium EVH1 and the 2 human homologs. At the start of development of 
embryos SMEK1 localises to the nucleus via the NLS at the C terminus (Mendoza et al., 2007).  
In Dictyostelium SMEK1 acts independently of MEK1 but regulates MEK1 effectors in an opposite 
manner to the MEK1/ERK1 pathways (Mendoza et al., 2007). SMEK1 functions in a complex with other 
factors regulated by the MEK1/ERK1 pathway (Mendoza et al., 2005).  
SMEK1 is excluded from the nucleus in Neural Stem/Progenitor Cells undergoing mitosis. This allows it 
to interact with Par3 (a cell polarity protein) and mediate dephosphorylation by PP4c (Lyu et al., 2013). 
1.2.3.3 DNA repair 
HDAC1 depletion increases histone H3 phosphorylation and deacetylation, which changes chromatin 
structure. The loss of PP4c complex also induces histone H3 phosphorylation/deacetylation (Lyu, Jho 
and Lu, 2011). SMEK1 recruits HDAC1, which forms the SMEK1/PP4c/HDAC1 complex; this performs 
histone acetylation in embryonic stem cells (Lyu, Jho and Lu, 2011; Martin-Granados et al., 2008). 
HDAC1 complex formation requires PP4c and SMEK1. When all three are combined, they suppress 
brachyury promoter in undifferentiated embryonic stem cells by deacetylating histones H3 and H4 (Lyu, 
Jho and Lu, 2011). SMEK1 recruits PP4c and HDAC1 to the promoter to mediate promoter suppression 
(Lyu, Jho and Lu, 2011).  
1.2.3.4 Apoptosis 
SMEK1 is a pro-apoptotic protein that is primarily located in the nucleus; however, its pathways and 
mechanisms are not well characterised (Byun et al., 2012; Chen et al., 2008b). It binds to proteins 
involved in apoptosis, and histone deacetylation (Byun et al., 2012). The balance of phosphate status of 
proteins regulates apoptosis (Mourtada-Maarabouni et al., 2003). Therefore, the balance between 
kinases and phosphatases controls the regulation of apoptosis.  
As SMEK1 is a regulatory protein of a phosphatase there are implications for PP4c in apoptotic 
pathways. SMEK1 activates transcription of p21 and p53 and targets the FAK/Akt/mTOR signalling 
pathway, which inhibits tumour growth and metastasis (Byun et al., 2012). Combining SMEK1 with 
germacitabine increases apoptosis by increasing Bax and reducing Bcl-xL and Bcl-2. It also up-regulates 
p53, and down-regulates NFκB (Dong et al., 2012; Byun et al., 2012). This works in contrast to PP4 
activation of NFκB (Martin-Granados et al., 2008; Yeh et al., 2004). 
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1.2.4 Other PPPs 
1.2.4.1 PP1 
PP1α and PP1γ have been shown to co-localise with RIG-1 in HeLa cells upon infection with Sendai 
Virus (SeV) (Wies et al., 2013). Interactions between RIG-1 and PP1α and PP1γ were also shown via 
co-immunoprecipitation in HEK239T cells post-SeV infection. This interaction was also confirmed in 
primary human lung fibroblasts infected with ΔNS1 influenza virus (Wies et al., 2013). Through knock 
out and directed mutagenesis experiments it was found that RIG-1 is crucial for IFN-inducing ability in 
response to viral infection. Dephosphorylation of RIG-1 by PP1 is essential for the ubiquitination of the 
CARD domain of RIG-1, and the resulting signal-transducing activity(Wies et al., 2013). However, this 
has not been confirmed in vivo, therefore there is a question over the relevance of this interaction.  
1.2.4.2 PP2A 
PP2A holds strong homology with PP4 (65% amino acid sequence). Both protein phosphatases are 
okadaic acid sensitive. Previous studies have used okadaic acid, which is a small molecule inhibitor 
produced by marine dionoflagelates (Swingle, Ni and Honkanen, 2007). Okadaic acid was widely used 
in studies to inhibit PP1 and PP2A, however it also inhibits PP4, PP5 and probably PP6 (Swingle, Ni and 
Honkanen, 2007). As PP4 has been more recently characterised, it has been said that some of the 
functions attributed to PP2A may belong to PP4 (Shui, Hu and Tan, 2007).  
1.2.5 Background to this research 
A yeast two-hybrid genome-wide screen was performed to identify human factors that interact with IAV 
M2 cytoplasmic domain that could have implications for our understanding of IAV lifecycle and influence 
on host cells and vice versa. Two other interactions with IAV M2 CT have been identified using data 
from the same screening. The human proteins already confirmed to interact with IAV M2 are Annexin A6 
and Cyclin D3 (Fan et al., 2017; Ma et al., 2012). This research will investigate a third interaction 
between M2 CT domain and human SMEK1/PP4R3α. Understanding the interaction could give insight 
into IAV processes within infected cells. This is especially important as SMEK1 is ubiquitously 
expressed, especially in lung tissues (Weizmann Institute of Science, 2015). 
1.2.6 Hypothesis and Aims 
1.2.6.1 Hypothesis 
No research has been published on SMEK1 regarding its roles during IAV infection. SMEK1 may be 
utilised by IAV to prevent early apoptosis during infection, though its interactions with Bax, Bcl-xl, Bcl-2, 
p53 and NFκB and the subsequent regulation of cell apoptosis. There is also the potential ability of 
SMEK1 to control cytokine response through its interactions with NFκB and IFN-1. Inhibition of SMEK1 
could lead to the development of antivirals with the ability to prevent IAV control of the cell cycle. 
If an interaction between M2 and Cyclin D3 arrests cells in G1/S phase, there are implications for PP4c 
function in S/G2 (Fan et al., 2017). If SMEK1 stimulation causes Cyclin D1 and CDK4 suppression, 
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which arrests cells in G1, this could have further implications on the Cyclin D3 pathway. The halt of the 
cell cycle by IAV in G1/S phase could have consequences if PP4 is also implicated in this. 
Negative regulation of type 1 interferon by PP4 could have serious implications due to the interaction 
between M2 and SMEK1. M2 could bind to SMEK1 and regulate the PP4 complex function through the 
regulatory subunit. IAV can thus negatively regulate type 1 interferon viral response through this 
interaction. This presents a novel pathway by which IAV interferes with host cell immune response.  
The hypothesis is that the interaction between SMEK1 and IAV M2 protein influences viral replication. 
This is due to the wide range of processes that the PP4 complex is involved in during IAV infection. The 
interaction with the SMEK1 subunit may result in the alteration of PP4 complex functions. 
 If IAV can inhibit regulation of type 1 IFN process through its interactions with SMEK1, then it presents a 
pathway through which it evades the innate response to infection. 
1.2.6.2 Aims 
To test the hypothesis, the first step is to clarify the results of the yeast two-hybrid screen. For this, an in-
silico analysis of the clones produced by the screen is required. The clones will then need to be aligned 
to identify homologous areas. The M2 binding domain will need to be identified as well as the other 
domains found on SMEK1. A literature search for known domains on SMEK1 and its homologs will need 
to be carried out to understand the differential functions of SMEK1 and its homologs.  
SMEK1 and PP4c expression need to be confirmed in A549 lung alveolar epithelial cells to understand 
the implications of interactions in lung cells. Cell lysates will be run on an SDS-PAGE gel and western 
blotting will be used to describe the expression of SMEK1 and PP4c in A549 cells. It is important to 
confirm the interaction of SMEK1 and IAV M2 by co-immunoprecipitation. A549 human lung epithelial 
cells will be infected with A/WSN/33 IAV and tested for SMEK1 and PP4c expression. Using 
Immunofluoresence assays and western blotting it is hoped that an effect will be seen on SMEK1 and 
PP4c expression levels and cellular localisation following infection.  
The overall aim of my project was to confirm an interaction between SMEK1 and M2, and to try to gain 
an understanding of the implications of this interaction. To achieve this, the set objectives were: 
(i) Analyse the cDNA clones identified through the Y2H screening to determine which SMEK1 
isoform and which specific motif interacted with M2 CT.  
(ii) Confirm the presence of SMEK1 and PP4c in the A549 lung epithelial cells used in the lab. 
(iii) Confirm the interaction between SMEK1 and M2 by co-immunoprecipitation 






Chapter 2: Materials and Method 
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2.1 Yeast two-hybrid screening 
The screening procedure performed by Hybrigenics, S.A., Paris, France 
(http://www.hybrigenics.com/homepage.html ), was described by Ma et al. (2012), used bait cloning from 
influenza A virus M2 domains. IAV M2 C-terminal (CT) domain (bait) was sub-cloned into plasmid vector 
pB27 to enable fusion with DNA binding domain. The vector was then transformed into the yeast strain 
L40∆GAL4. A random-primed human placenta cDNA library was subcloned into the pLexA plasmid 
vector in frame with a DNA activation domain. The vector was then transformed into the yeast strain 
L40∆GAL4. A random-primed human placenta cDNA library was transformed into a vector containing a 
DNA activation domain. The human placenta cDNA library contained 10 million independent fragments.  
This vector was transformed into the Y187 yeast strain. Y187 and L40∆GAL4 were mated; using a 
specific mating method increased efficiency. A small-scale screening was used to allow the bait to adapt 
to selective pressure (selective mediums) (Rain et al., 11). Toxicity and auto activation were not seen. 
The full screening was then performed to allow a minimum of 50 million interactions to be tested. This 
covered five times the primary complexity of the yeast-transformed cDNA library (Rain et al., 11). 
273 fragments were picked following selection on a medium lacking leucine, tryptophan and histidine. 
These fragments were subjected to PCR and sequencing at the 5” and 3” ends. The sequences were 
filtered, divided into a contig and compared to the GenBank database using BLASTN. Each interaction 
was given a predicted biological score to define the reliability of the interaction (Ma et al., 2012; Millet et 
al., 2012; Teoh et al., 2010). The predicted biological score (PBS) was defined by accounting for 
redundancy and independency of prey fragments; other factors were the distributions of reading frames 
and stop codons in overlapping fragments. False positives were given a score of “E”. These scores have 
been shown to correlate to the significance of the interactions (Rain et al., 11). 20 cDNA clones were 
identified to correspond to the KIAA2010 (SMEK1) protein.  
2.2 In silico analysis 
2.2.1 Alignment of cDNA sequences 
The nucleotide sequences corresponding to the 20 cDNA clones identified in the yeast two-hybrid 
screen were saved in FASTA format and aligned using CLUSTAL OMEGA 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). cDNA sequences were entered; parameters were set for the 
output format as CLUSTAL without numbers. This produced a contig which determined the overlapping 
regions in these cDNAs and identified the longest and shortest clones. Subsequent protein sequence 
alignments were also performed using CLUSTAL OMEGA.  
2.2.2 Translation of cDNA into protein sequence 
Following alignment of the 20 clones, the M2-binding domain was identified as the common region 
between contig. The common region was translated using ExPASY translation tool 
(http://web.expasy.org/translate/).  
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2.2.3 Protein sequence alignments 
The translated protein sequence was searched for non-redundant protein sequence matches using 
BLASTp database (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins). This is where conserved 
proteins and isoforms were found. The isoforms of SMEK1 in Homo sapiens were searched in NCBI 
database (https://www.ncbi.nlm.nih.gov/); isoforms’ protein sequences were identified and then aligned 
using CLUSTAL OMEGA database to identify deletions. The Gene Cards database 
(http://www.genecards.org/) was also searched for any information on isoforms.  
2.3 Cells and viruses 
Human alveolar basal epithelial cells (A549), Madin-Darby canine kidney cells (MDCK) and cervical 
cancer epithelial HeLa cells (HeLa), were grown in Dulbecco’s modified eagle medium (DMEM) 
supplemented with 10% fetal bovine serum (FBS) and 100µ/ml penicillin streptomycin at 37oC in humid 
atmosphere supplemented with 5%CO2. 
2.3.1 Viral Amplification 
Influenza A virus strains used were A/WSN/33 (H1N1) and A/Udorn/72 (H3N2). 
The virus was propagated in MDCK cells serum-free DMEM medium supplemented with: 1µg/ml 
tusylsulfonyl phenylalnyl chloromethyl ketrone (TPCK)-treated trypsin, 100µ/ml penicillin streptomycin 
and 0.5% BSA.  
2.3.2 Viral Titration 
Viral titre was determined by tissue culture infectious dose assay in 50% of inoculated cells (TCID50) 
assay on MDCK cells. A dilution of 10-2 virus/ml was prepared, which was serially diluted across the 96 
well plate. This created a serial dilution of 1/2log10 (10-2, 10-2.5, 10-3, 10-3.5, 10-4, 10-4.5, to 10-7.5); column 12 
was left as a negative infection control.  Virus stock was added and left for 1 hour to attach to the 96 well 
plate, before 1x105 cells were added to each well. 100µl of infection medium was added to each well and 
left for 3 days. After three days, the numbers of infection-positive wells at each dilution were counted 
using the Reed-Muench algorithm to calculate the concentration of the virus. The principle behind the 
algorithm calculates the TCID50 of the starting viral dilution by measuring the concentration at which 50% 
of wells are infected (limiting dilution). This algorithm can calculate the number of plaque-forming units 
(pfu) in a suspension of virus. The wells were counted to find a dilution where 50% of wells were infected 
(another algorithm was used to calculate proportional distance if this did not occur); this dilution was the 
limiting dilution. The theory was that if only 50% of wells were infected at that dilution, infected wells 
were infected by one or two pfu.  
TCID50/ml = 20 X Limiting Dilution 
To calculate proportional distance =   % positive wells >50% - 50 
     % positive wells >50% - % positive value <50% 
Proportional distance was added to dilution showing >50% position wells.  
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To get pfu instead of TCID50 = TCID50 / 0.7 
2.4 Infection of A549 cells for western blot and IFA 
Sterile glass coverslips were placed in 10cm3 petri dishes. They were coated with 0.01% collagen in 
ddH20 and left for 2 hours at 37oC or overnight at 4oC. Cells were plated with 5ml complete medium. 
They grew to 80% confluence. Once they had reached this confluency they were washed twice with PBS 
before an appropriate amount of viral suspension was added to the petri dish. The amount of viral 
suspension added depended on the viral titre and the multiplicity of infection (MOI) required for the 
infection. The virus could bind to the surface of the cells for 1 hour at 37oC (tilted every 15 minutes to 
ensure complete coverage). After binding the viral suspension was removed and 3 ml of infectious 
medium were added to the petri dishes to allow the virus to enter the cells. The dishes were left in an 
incubator at 37oC for the allotted time for each time point. Fixation of cells was dependent on the method 
of analysis.  
2.5 Antibodies 
The following antibodies were used during analysis. Dilutions are indicated for relevant techniques: 
- Rabbit anti-SMEK1 ab70635, IgG polyclonal antibody corresponding to 770-820 (C-terminus) on 
protein ID NP_115949.1. Immunoprecipitation concentration 2µg per mg of lysate, Western blot 
concentration 1:2000 (Abcam, Cambridge).  
- Rabbit anti-PP4c catalogue number A300-835A-M, IgG polyclonal antibody corresponding to 
residue 1-50 on protein ID NP_002711.1, gene ID 5531. Immunoprecipitation concentration, 
Immunofluorescence concentration 1:50, Western blot concentration 1:1000 (Bethyl). 
- Rabbit anti-SMEK1 catalogue number A300-840A-M, IgG polyclonal antibody corresponding to 
residue 770-820 (C-terminus) on protein ID NP_002711.1, gene ID 5531. Immunoprecipitation 
concentration, Immunofluorescence concentration 1:50, Western blot concentration 1:2000 (Bethyl). 
- Mouse anti-M2, ab5416, IgG1, monoclonal clone 14C2. Western blot concentration 1:1000 
(Abcam, Cambridge). 
- Mouse anti-GAPDH, mabcam 9484, monoclonal ab9484. Western blot concentration 1:1000 
(Abcam, Cambridge). 
- Rabbit anti-Annexin-A6 gene ID 309 polyclonal antibody, catalogue number PAB18085 
Immunoprecipitation concentration (Abnova). 
- Rabbit anti-NFκB (c-20) catalogue number Sc372, corresponding to c-terminus of p65 subunit, 
concentration for immunoprecipitation (Santa Cruz). 
- Mouse anti-M1, MCA401, IgG, Immunofluorescence concentration 1:100 (AbD serotec). 
- Anti-rabbit HRP from donkey, NA 934-1ML, western blotting concentration 1:1000 (Amersham, 
GE Healthcare).  
- Anti-mouse HRP from sheep, NA931-1ML, western blotting concentration 1:1000 (Amersham, 
GE Healthcare). 
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- Alexa 488 goat anti-rabbit, Invitrogen UK, polyclonal IgG (H+L), Immunofluorescence 
concentration 1:100. 
- Texas Red rabbit anti-mouse, Jackson ImmunoResearch, polyclonal IgM µ Chain Specific, 
Immunofluorescence concentration 1:100. 
2.6 BCA Assay 
Samples were analysed for protein concentration with a nanodrop spectrophotometer (Nanodrop2000). 
A working reagent was prepared at a 50:1 ratio of kit reagents A and B (BCA kit, ThermoFisher, 23225). 
For each sample, 200µl of working reagent was added to 10µl of sample into clean Eppendorf tubes. In 
parallel, standards were prepared to make a standard curve. For this, 200µl of working reagent was 
added to 7 tubes (A-G). 10µl of pre-diluted BSA (2mg/ml) was added to tube A. 10µl was serially diluted 
from tube A-G (1/20 dilutions), ensuring that tubes were well mixed. BSA was diluted serially to final 
BSA concentrations of 2000, 1500, 1000, 750, 500, 250, 125, 25 and 0 µg/ml. The standards and 
samples were incubated at 37oC for 30 minutes. 2µl of standard/sample was vortexed, added to the lens 
and analysed by Nanodrop2000 at 280nm wavelength.  
2.7 Western blot 
For western blot analysis for fractionated lysates, cells were washed twice with PBS, then lysed with 
400µl of lysis buffer (Table 2) on ice for 15 minutes. The cells were then scraped and the lysis buffer, 
containing cell lysates, was collected. Cell lysates were centrifuged at 13000 rpm for 1 hour at 4oC. The 
supernatant was removed and the pellet was re-suspended in 200µl of lysis buffer. The supernatant 
contained the soluble fraction of the cell lysates; this contained cytosol and solubilised membranes of 
lysed cells. The re-suspended pellet contained the insoluble fraction of the cell lysates; this contained 
the nuclear debris, insoluble membranes and cytoskeleton components. 
Using the western blot lysis technique for whole cell lysates, cells were washed twice with PBS, 
trypsinised and centrifuged twice at 12000rpm for 5 minutes. Cells were then counted using a 
haemocytometer and 100µl of lysis buffer (Table 2) was added for every 1x106 cells. The lysates were 
centrifuged and heated for 5 minutes at 100oC. Anti-protease cocktail (Fisher Bioreagents BPE970-1) 
was added immediately after heating at a 1:1000 dilution. Lysates were then frozen at -20oC until 
required.  
For western blotting, fractionated protein samples were solubilised in loading buffer (Table 2). 10mM 
dithiothreitol (DTT) was added and samples were boiled at 95oC for 5 minutes. They were then loaded 
into 8% Bis-Tris mini gel (Table 2 for resolving and stacking buffer) for separation by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The samples were run at room temperature at 
250V until the loading buffer ran to the end of the gel. Hybond-P polyvinylidene difluoride (PVDF) 
membrane was dehydrated in 100% ethanol and rehydrated in ddH2O. Separated proteins were 
transferred to a PVDF membrane (Amersham Biosciences) overnight at 4oC in transfer buffer (Table 2) 
at 30V. The membrane was blocked for 1 hour in 5% semi-skimmed milk in PBS-T (PBS containing 
0.01% Tween 20). The membrane was hybridised with primary antibody in PBS-T 5% semi-skimmed 
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milk (SMEK1, M1, M2, Annexin A6 and NFκB) or 5% BSA (GAPDH, PP4c) for 1 hour. It was washed in 
PBS-T 5% semi-skimmed milk and hybridised with secondary antibody in PBS-T 5% semi-skimmed milk 
for 1 hour. Following washing, the membrane was covered in Amersham ECL Prime western blotting 
detection reagent for 2 minutes, exposed to Amersham Hyperfilm ECL X-ray film and developed.  
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Lysis Buffer (for soluble/insoluble fractions) 1% Triton X100 
20mM Tris-HCl ph 7.5 
150mM NaCl 
1mM EDTA  
(prepared as a stock) 
Anti-protease cocktail added immediately before 
use at 1:1000 
Lysis Buffer (for whole cell lysates) 1ml 1M tris-HCl pH 6.8 
4ml 10% SDS 
2ml Glycerol 
0.5ml β-mercaptoethanol 
Dab of Bromophenol blue powder 
Topped up with ddH20 to 10ml and aliquoted 
Resolving Buffer (for 2 gels) 3ml 40% Acrylamide/Bis,  





Stacking Buffer (for 2 gels) 0.5ml 40% Acrylamide,  





Running Buffer Tris Base 4.5g, 
Glycine 34g, 
SDS 1.5g 
Loading Buffer 5X (not required for whole cell 
lysates) 





Transfer Buffer 2.4g Tris base 20mM 
11.6g Glycine 150mM, 
10ml SDS 0.2% 
200ml Ethanol 20% 
1.29L ddH2O 
Table 2. Various buffers used for SDS PAGE electrophoresis analysis.  
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2.8 Dot Blot 
PVDF membrane was dehydrated in 100% ethanol and rehydrated in ddH2O. The membrane could dry 
for approximately 1 hour before adding varying amounts of crude cell lysates to the membrane. This was 
left to dry again for approximately 1 hour before blocking the membrane for 1 hour in 5% BSA in PBS-T 
(PBS containing 0.01% Tween 20). The membrane was hybridised with primary antibody in PBS-T 5% 
semi-skimmed milk (SMEK1) or 5% BSA (GAPDH, PP4c) for 1 hour. It was washed in PBS-T 5% semi-
skimmed milk and hybridised with secondary antibody in PBS-T 5% semi-skimmed milk for 1 hour. 
Following washing, the membrane was covered in ECL western blotting reagent for 2 minutes, exposed 
to Amersham Hyperfilm ECL X-ray film and developed.  
 
2.9 Immunofluorescence assay 
For the immunofluorescence assay (IFA), cells were plated on autoclaved coverslips within the petri dish 
(preparation described above). These were washed twice with PBS and placed in a 6-well plate with 1ml 
of 4% PFA (parafolmadehyde) for 2 hours at room temperature or overnight at 40C. The coverslips were 
then washed twice with PBS before IFA labelling could occur.  
Coverslips were quenched with 50mM NH4Cl for 15 minutes and permeabilised with TritonX100 0.1% for 
5 minutes on ice. The next steps took place on parafilm attached to a flat surface; cells were placed 
facing down on drops of solution. Coverslips were washed again in PBS before blocking with 40µl of 
10% Normal Donkey Serum (NDS) for 1 hour. They were washed in PBS before being added to 5% 
NDS solution containing various primary antibodies for 1 hour (rabbit anti-SMEK1 from Bethyl, rabbit 
anti-PP4c, mouse anti-M2). Additionally, some coverslips were incubated in 5% NDS without antibodies 
as a secondary antibody control. Coverslips were washed again in PBS and added to 5% NDS with 
various secondary antibodies for 45 minutes (Alexa 488 anti-rabbit Invitrogen 1:100, Texas Red anti-
mouse Jackson ImmunoResearch 1:100). Following that, coverslips were washed in PBS and ddH20 
before being placed on pre-washed microscope slides with 9µl drops of DABCO or Vectashield 
mounting medium and left to dry. Once dry they were sealed with clear nail varnish to prevent movement 
and viewed using HF14 Leica DM4000 microscope. Images were acquired using secondary only 
labelled coverslips as a control for measuring background signal. The same acquisition conditions 
(exposure time etc.) were used for each immunofluorescence channel for all images in one experiment. 
Image analysis was performed on Image J. On the ‘analyse’ menu, ‘set measurements’ was selected, 
ensuring area, integrated density and mean grey value were chosen. The cell of interest was selected 
using the freeform drawing tool. The cell was measured by selecting ‘measure’ from the ‘analyse’ menu. 
Background was measured by using the circle-drawing tool to measure three areas surrounding the cell 
of interest. This was repeated for all cells in the image. For non-infected cells, or where no cells could be 
seen, background readings were taken in place of cell area. Values for each cell were copied into Excel 
and the following formula was used to calculate corrected total cell fluorescence (CTCF). 
CTCF = Integrated Density – (Area of selected cell X Mean fluorescence of background readings) 
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The average CTCF was taken and the values used in a graph.  
2.10 Co-Immunoprecipitation Assay 
Co-Immunoprecipitation assay was performed using Thermo Fisher Pierce Classic Immunoprecipitation 
kit.  
A549 cells were infected and lysed in the same way as for western blot analysis, except that the lysis 
buffer provided by the manufacturer (Thermo Fisher) was used. Lysate was transferred to 
microcentrifuge tubes and centifuged at 13000g for 10 minutes to pellet cellular debris. Some 
supernatant was transferred to a new tube for protein concentration determination. 20µl total lysate was 
saved as a control. Per 1mg of cell lysate 80µl of control agarose resin slurry (40µl of settled slurry) was 
added into a spin column. The column was centrifuged to remove the storage buffer. 100µl of 0.1M 
sodium phosphate and 0.15M sodium chloride pH7.2 were added to the column, centrifuged and the 
flow-through was discarded. 1mg of lysate was added to the column containing resin and incubated at 
4oC for 30 minutes to 1 hour with gentle end-over-end mixing. The column was centrifuged for 1 minute 
at 1000g. The column containing resin was discarded and flow-through saved (20µl of precleared lysate 
was saved as a control). The amount of sample added was dependent on the antibody-antigen system. 
2-10µg of affinity purified antibody was combined with pre-cleared lysate in a microcentrifuge tube (total 
protein per IP reaction should be 500µg). Antibody/lysate solution was diluted with IP lysis/wash buffer 
and incubated overnight at 4oC to form the immune complex. The solution was combined with loading 











3.1.1 In Silico analysis of human SMEK1 gene, protein and homologs 
An in silico analysis of SMEK1 was conducted. This was because there were no review articles on 
SMEK1 or PP4 that could provide comprehensive analysis or information on SMEK1. The purpose of the 
in silico analysis was to clarify the domains, size, functions and isoforms of SMEK1. This was important, 
as it allowed an understanding the structure of the SMEK1 isoform identified, how it compares with other 
isoforms, how domains are organised in the protein product and what is the domain involved in M2 
interaction. We could then develop a full understanding of the implications of any alterations to normal 
expression that might have been seen following IAV infection. Without understanding normal SMEK1 
expression, nothing could be accurately deduced from IAV altered expression. 
3.1.1.1 Analysis of SMEK1 cDNA clones and production of cDNA contig 
Twenty clones corresponding to isoform 1 were produced by the yeast two-hybrid screen, performed by 
Hybrigenics (Paris) (Table 3). The longest and shortest clones were identified by CLUSTALW alignment 
of all clones; they were then translated using ExPASY translation. The longest translated clone 
sequence was searched in the BLASTp database. The shortest cDNA was clone number 79, which 
encoded a polypeptide that is 369 amino acids in length and is found at position 372-741 on the full-
length protein. Its protein sequence can be found in Table 4 Appendix 9 (i). Three clones were identified 
to be the longest, but clone 294 had the highest percentage identity (Table 3) as per the results of the 
screen and was thus selected as the longest clone. Clone 294 encodes a protein of 479 amino acids in 
length and can be found at 340-819 on the full-length protein. Its protein sequence can be found in Table 
4 Appendix 9 (i). These clones were then aligned again to confirm the M2 binding domain; the alignment 
is shown in Figure 6. The area found to be common between all clones is the area that has successful 
bound to M2 during the yeast two-hybrid screen. Therefore, the area common to all clones can be 
identified as the M2 binding domain. 
The first 3 results of the protein database search with 100% identity were an unnamed protein accession 
number BAB14877.1 (cDNA sequence project), KIAA2010 accession number EAW81454.1 (human 
genome sequence) and PP4R3α accession number NPO01271209. The shortest clone was also 
searched through BLASTp; this clone is very highly conserved and produced a high volume of matches. 
The longest and shortest clones were then aligned with PP4R3α sequence found through the BLASTp 
search, to identify the location of these clones on the full-length protein. Through aligning the longest 
and shortest clones (294 and 129), the common region was translated with ExPASY translation tool.  A 
contig of the translated short and long clones and full protein can be found in Figure 6. This protein 
sequence was searched in the BLAST database to find conserved proteins and isoforms. The isoforms 
of SMEK1 were searched in NCBI database to allow for a run of alignment of protein sequences on 





































PLA_RP_hgx1492v1_pB27_A-294	 5p	3p		 18635238	 A	 99.9	/	99.7	 1020	 2418	 IF	
PLA_RP_hgx1492v1_pB27_A-137	 5p	3p		 18635238	 A	 99.7	/	99.9	 1020	 2418	 IF	
PLA_RP_hgx1492v1_pB27_A-339	 5p	3p		 18635238	 A	 97.6	/	99.7	 1020	 2418	 IF	
PLA_RP_hgx1492v1_pB27_A-142	 5p	3p		 18635238	 A	 99.5	/	99.4	 1062	 2337	 IF	




100.0	 1062	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-207	 5p	3p		 18635238	 A	 98.6	/	99.2	 1062	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-39	 5p	3p		 18635238	 A	 91.0	/	93.0	 1071	 2337	 IF	




100.0	 1071	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-276	 5p	3p		 18635238	 A	 99.7	/	99.6	 1071	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-102	 5p	3p		 18635238	 A	 99.3	/	99.9	 1071	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-88	 5p	3p		 18635238	 A	 90.5	/	91.7	 1071	 2337	 IF	
PLA_RP_hgx1492v1_pB27_A-79	 5p	3p		 18635238	 A	 97.2	/	92.0	 1116	 2186	 IF	
PLA_RP_hgx1492v1_pB27_A-123	 5p	3p		 18635238	 A	 98.8	/	99.6	 1116	 2186	 IF	
PLA_RP_hgx1492v1_pB27_A-128	 5p	3p		 18635238	 A	 99.6	/	99.1	 1116	 2186	 IF	





Table 3. The information regarding clones identified through the yeast two-hybrid screen. The clone 
name comprises of the programme used (PLA_RP), screen name (hgx1492v1), vector (pB27) and 
individual clone number beginning with A. Type of sequence describes whether the sequence is 3” or 5”. 
Global PBS score describes the confidence in the interaction, A shows very high confidence in the 





Figure 6. Alignment of PP4R3α isoform 1, clone 294 (longest clone) and clone 129 (shortest clone). This 
was performed using BLASTN alignment tool. Overlapping areas of the sequences identify the proposed 
M2 binding domain.  
The isoform found through this yeast two-hybrid screen was identified as isoform 1. This has a deletion 
of 12 amino acids from 410-422 of VSKKLTEQKITSK, which is a poly-lysine insert. Another isoform, 
isoform 3, has a larger deletion, 67 – 305; this resulted in a small 594 amino acid chain. The result of the 
loss of this sequence would cause deletion of much of the DUF625 domain; this could negate the 
PP4R3a_iso1      MTDTRRRVKVYTLNEDRQWDDRGTGHVSSGYVERLKGMSLLVRAESDGSLLLESKINPNT 60 
pB27_A-294       ------------------------------------------------------------ 0 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      AYQKQQDTLIVWSEAENYDLALSFQEKAGCDEIWEKICQVQGKDPSVDITQDLVDESEEE 120 
pB27_A-294       ------------------------------------------------------------ 0 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      RFDDMSSPGLELPSCELSRLEEIAELVASSLPSPLRREKLALALENEGYIKKLLELFHVC 180 
pB27_A-294       ------------------------------------------------------------ 0 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      EDLENIEGLHHLYEIIKGIFLLNRTALFEVMFSEECIMDVIGCLEYDPALSQPRKHREFL 240 
pB27_A-294       ------------------------------------------------------------ 0 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      TKTAKFKEVIPISDPELKQKIHQTYRVQYIQDMVLPTPSVFEENMLSTLHSFIFFNKVEI 300 
pB27_A-294       ------------------------------------------------------------ 0 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      VGMLQEDEKFLTDLFAQLTDEATDEEKRQELVNFLKEFCAFSQTLQPQNRDAFFKTLSNM 360 
pB27_A-294       ---------------------------------------XFSQTLQPQNRDAFFKTLSNM 21 
pB27_A-129       ------------------------------------------------------------ 0 
                                                                              
 
PP4R3a_iso1      GILPALEVILGMDDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDDDILLINLIIEH 420 
pB27_A-294       GILPALEVILGMDDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDDDILLINLIIEH 81 
pB27_A-129       ------------XDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDDDILLINLIIEH 48 
                              *********************************************** 
 
PP4R3a_iso1      MICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGFFYKHCMHVLTAPLLANT 480 
pB27_A-294       MICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGFFYKHCMHVLTAPLLANT 141 
pB27_A-129       MICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGFFYKHCMHVLTAPLLANT 108 
                 ************************************************************ 
 
PP4R3a_iso1      TEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDILRRVLVLMASKHAFLAL 540 
pB27_A-294       TEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDILRRVLVLMASKHAFLAL 201 
pB27_A-129       TEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDILRRVLVLMASKHAFLAL 168 
                 ************************************************************ 
 
PP4R3a_iso1      CALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNLMNSAIIEMFEFIRVEDI 600 
pB27_A-294       CALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNLMNSAIIEMFEFIRVEDI 261 
pB27_A-129       CALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNLMNSAIIEMFEFIRVEDI 228 
                 ************************************************************ 
 
PP4R3a_iso1      KSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDNPKLDSMRSILRNHRYRRDAR 660 
pB27_A-294       KSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDNPKLDSMRSILRNHRYRRDAR 321 
pB27_A-129       KSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDNPKLDSMRSILRNHRYRRDAR 288 
                 ************************************************************ 
 
PP4R3a_iso1      TLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIMDPISKFMERKKLKESEEKEVLLK 720 
pB27_A-294       TLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIMDPISKFMERKKLKESEEKEVLLK 381 
pB27_A-129       TLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIMDPISKFME--------------- 333 
                 *********************************************                
 
PP4R3a_iso1      TNLSGRQSPSFKLSLSSGTKTNLTSQSSTTNLPGSPGSPGSPGSPGSPGSVPKNTSQTAA 780 
pB27_A-294       TNLSGRQSPSFKLSLSSGTKTNLTSQSSTTNLPGSPGSPGSPGSPGSPGSVPKNTSQTAA 441 
pB27_A-129       ------------------------------------------------------------ 333 
                                                                              
 
PP4R3a_iso1      ITTKGGLVGLVDYPDDDEDDDEDEDKEDTLPLSKKAKFDS 820 
pB27_A-294       ITTKGGLVGLVDYPDDDEDDDEDEDK-------------- 467 
pB27_A-129       ---------------------------------------- 333 
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function of SMEK1 to recognise PP4c for binding. CLUSTAL OMEGA alignment of isoforms allowed 
identification of deleted regions found in Figure 7.  
 
3.1.1.2 SMEK1 isoform 1 was isolated through the screen 
The yeast two-hybrid screen identified isoform 1, an 820-amino acid sequence with a deletion of 
409:422 (as found on longest isoform sequence). This is different to the sequence found on the Gene 
Cards database, which is an 833-amino acid sequence. The variety of identified isoforms led to a search 
for other isoforms of SMEK1; 3 isoforms were found on NCBI protein database. Isoform 1 is missing 
409:422, isoform 3 is missing 67:305; isoform 4 is the full-length protein. SMEK1 sapiens was then 
searched in NCBI nucleotide database to identify the transcript variants that led to these isoforms. 
Transcript variant 2 is missing 410:420, transcript variant 5 is also missing 410:420, but is an incomplete 
non-translatable variant. NCBI database, Gene Cards database and published papers were then 
searched for the domains of SMEK1, shown in Figure 7.  
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3.1.1.2 Protein Domains 
There were five domains on SMEK1: Pleckstrin-homology domain (PH domain), Domain of unknown 
function (DUF625), Armadillo-type fold (ARM), Ran binding domain (RanBD) and M2 binding domain 
(M2 BD). These domains were found through alignment of yeast two-hybrid screening clones 
(Weizmann Institute of Science, 2015). 
The RanBD domain was found through literature analysis (Lyu et al., 2013; Mendoza et al., 2007). This 
was the most conserved portion of SMEK1, which contained a 115-amino acid fragment at the N-
terminal.  
DUF625 is crucial to SMEK1 function and SMEK1 participation in neurogenesis. DUF625 binds to the 
Par3 c-terminus. Par3 is a negative regulator of neurogenesis, which is in turn negatively regulated by 
PP4. This is important for neuronal differentiation as Par3 critically regulates proliferation as opposed to 
differentiation during cortical development(Lyu et al., 2013). The central DUF625 mediates SMEK1 
function and participates in neurogenesis alongside the RanBD domain (N-terminal Ran-binding domain) 
(Lyu et al., 2013; Mendoza et al., 2007). The DUF625 is also important for Par3/ SMEK1 interaction with 
the coiled-coil region of Par3, enabling PP4c dephosphorylation of Par3 (Lyu et al., 2013). Following the 
DUF625 is a variable amount of armadillo (ARM) repeats; these regulate neuronal differentiation through 
PP4c (Lipinszki et al., 2015; Lyu et al., 2013).This explains why PP4 knock out mice are embryonically 
lethal (Wang et al., 2008). Without proliferation, embryos are not able to develop. RanBD (Ran binding 
domain) mediates SMEK1 function in cell cycle, through binding to Ran. SMEK1 cytoplasmic/cortical 
localisation during mitosis is essential for PP4 to target Par3 during development (Lyu et al., 2013) 
Poly-lysine inserts can be found at 410:422, as found in the amino acid sequence: VSKKLTEQKITSK. 
This insert was found in all isoforms except isoform 1.  
The EVH1 domain in SMEK1 is required for SMEK1 localisation to the cell cortex during vegetative 
growth where is it is required for proper cytokinesis (Mendoza et al., 2007). 
3.1.1.2.3 Definition of the SMEK1 M2-binding domain 
Shown in Figure 7 are the longest and shortest clones found through the yeast two-hybrid screen. They 
are arranged to show their position relative to PP4R3a/SMEK1 isoforms. Clone 294 is the longest clone 
and includes the serine stretch, which contains 6 serine’s at positions 741, 768, 771, 774, 777 and 780. 
Clone 129 is the shortest clone and was identified as the M2-binding domain. It does not contain the 
serine rich area found in the longest clone and all isoforms. Both clones are homologous to isoform 1 in 
the respect that they also lack the poly-lysine insert, which is found in isoform 4 and 3. It was by this 
logic that it was deduced that the SMEK1 isoform identified in the yeast two-hybrid screen was isoform 
1. This could mean that M2 can only bind this isoform 1. It could also mean that the placenta library was 
enriched in isoform 1 clones or the placenta library did not contain clones for other isoforms, thus no 
other isoform clones were identified. 
In silico identification of the M2 binding domain through clone alignment identified an overlap with the 
ARM domain. It was found that the M2 binding domain was adjacent to the DUF 625 domain shown in 
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Figure 7. The ARM domain is required for PP4-SMEK1 complex formation as a recognition site for 
PP4(Lyu et al., 2013). SMEK1 is important for PP4 localisation, therefore the ARM domain acts as a 
binding site for PP4; this is essential for nuclear localisation of the PP4 complex (Lyu et al., 2013). The 
M2 binding domain overlaps with the ARM repeats which are important for PP4 recognition of SMEK1. 
This could have implications for PP4 and SMEK1 binding following IAV infection, although this is an area 
yet to be researched. 
 
Figure 7. Full length Protein SMEK1 and clones 294 and 129. M2 binding domain is shown, as well as 
the amino acid position of each domain on the full-length protein and the longest and shortest clone 
fragments. Important domains found the literature search has identified RanBD, the EVH1 domain, the 
PH (Pleckstrin-homology) domain, which also overlaps with the RanBD and EVH1 domains at the N-
terminus and a poly-lysine insert with potential phosphorylation sites. DUF625 (domain of unknown 
function 625, also referred to as the SMEK1 domain), overlaps with the ARM (armadillo-type fold) 
repeat. At the C-terminus there is a nuclear localisation sequence (NLS). Below this are the longest 
(294) and shortest (129) clones of 369 and 479 amino acids in length respectively.  
3.1.1.4 Similarity of human SMEK1 with orthologs 
An alignment was performed using: SMEK1 (Human) accession number AAH72409.1, clone 294, 
FALAFEL isoform E (Drosophila) accession number NP_731850.2 and PP4R3α isoform 1 (Human) 
accession number NP_001271209.1, shown in Figure 8. The phylogenic tree showed that FALAFEL and 




Figure 8. Alignment of: Drosophila FALAFEL isoform E (>NP_731850.2), Human SMEK1 isoform 1 
(>AAH72409.1), Clone 294 from the yeast two-hybrid screen (> pB27_A-294) and Human PP4R3α (> 
NP_001271209.1).  A phylogenic tree below shows similarity between sequences. 
 
NP_731850.2         MTTDTRRRVKLYALNAERQWDDRGTGHVSSTYVERLKGISLLVRAESDGSLLLESKIQPD 
AAH72409.1          -MTDTRRRVKVYTLNEDRQWDDRGTGHVSSGYVERLKGMSLLVRAESDGSLLLESKINPN 
pB27_A-294          ------------------------------------------------------------ 
NP_001271209.1      -MTDTRRRVKVYTLNEDRQWDDRGTGHVSSGYVERLKGMSLLVRAESDGSLLLESKINPN                                                                                    
 
NP_731850.2         TAYQKQQDTLIVWSEGDNFDLALSFQEKAGCDEIWEKICQVQGKDPSVEITQDIVEESED 
AAH72409.1          TAYQKQQDTLIVWSEAENYDLALSFQEKAGCDEIWEKICQVQGKDPSVDITQDLVDESEE 
pB27_A-294          ------------------------------------------------------------ 
NP_001271209.1      TAYQKQQDTLIVWSEAENYDLALSFQEKAGCDEIWEKICQVQGKDPSVDITQDLVDESEE                                                                                    
 
NP_731850.2         ERFEDMSDTAPPIELPPCELSRLEDISETIQSCLSTPLRKEKLSMALESESYIKKLLNLF 
AAH72409.1          ERFDDMS--SPGLELPSCELSRLEEIAELVASSLPSPLRREKLALALENEGYIKKLLELF 
pB27_A-294          ------------------------------------------------------------ 
NP_001271209.1      ERFDDMS--SPGLELPSCELSRLEEIAELVASSLPSPLRREKLALALENEGYIKKLLELF                                                                                    
 
NP_731850.2         HVCEDLDNTEGLHHLFEIFKNIFLLNKNALFEIMFADDTIFDVVGCLEYDPSVSQPKKHR 
AAH72409.1          HVCEDLENIEGLHHLYEIIKGIFLLNRTALFEVMFSEECIMDVIGCLEYDPALSQPRKHR 
pB27_A-294          ------------------------------------------------------------ 
NP_001271209.1      HVCEDLENIEGLHHLYEIIKGIFLLNRTALFEVMFSEECIMDVIGCLEYDPALSQPRKHR                                                                                    
 
NP_731850.2         QYLKQLAKFREAVPIKNLDLLAKIHQTFRVQYIQDIILPTPSVFVEDNMLNTLSSFIFFN 
AAH72409.1          EFLTKTAKFKEVIPISDPELKQKIHQTYRVQYIQDMVLPTPSVFE-ENMLSTLHSFIFFN 
pB27_A-294          ------------------------------------------------------------ 
NP_001271209.1      EFLTKTAKFKEVIPISDPELKQKIHQTYRVQYIQDMVLPTPSVFE-ENMLSTLHSFIFFN                                                                                    
 
NP_731850.2         KVEIVTMIQDDERYLLDVFAVLTDPTTGDAKRRDTVLFLKEFCNYAQNLQPQGKDSFYKT 
AAH72409.1          KVEIVGMLQEDEKFLTDLFAQLTDEATDEEKRQELVNFLKEFCAFSQTLQPQNRDAFFKT 
pB27_A-294          -------------------------------------------XFSQTLQPQNRDAFFKT 
NP_001271209.1      KVEIVGMLQEDEKFLTDLFAQLTDEATDEEKRQELVNFLKEFCAFSQTLQPQNRDAFFKT  
           ::*.****.:*:*:** 
NP_731850.2         LTCLGILQALELTLVMNDKKTKSASIDILTAIVEFSPLVVRNYTLNQANRP--------- 
AAH72409.1          LSNMGILPALEVILGMDDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDDVSKKLTE 
pB27_A-294          LSNMGILPALEVILGMDDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDD------- 
NP_001271209.1      LSNMGILPALEVILGMDDTQVRSAATDIFSYLVEYNPSMVREFVMQEAQQNDD------- 
          *: :*** ***: * *:*.:.:**: **:: :**:.* :**::.:::*:: 
NP_731850.2         ----EVERMLLNIAIEQMLNDSEPELGIAVQLMGIVKILLEPENMLT-----EKGDFLNF 
AAH72409.1          QKITSKDILLINLIIEHMICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGF 
pB27_A-294          ------DILLINLIIEHMICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGF 
NP_001271209.1      ------DILLINLIIEHMICDTDPELGGAVQLMGLLRTLVDPENMLATANKTEKTEFLGF 
       : :*:*: **:*: *::**** ******::: *::*****:     ** :**.* 
NP_731850.2         FYKYSVQTLVAPVILNTIGDRPQNEDYQTAQLLGIVLDILSFCVEHHSYHIKNFLLQKDL 
AAH72409.1          FYKHCMHVLTAPLLANTTEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDI 
pB27_A-294          FYKHCMHVLTAPLLANTTEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDI 
NP_001271209.1      FYKHCMHVLTAPLLANTTEDKPSKDDFQTAQLLALVLELLTFCVEHHTYHIKNYIINKDI 
          ***:.::.*.**:: **  *:*.::*:******.:**::*:******:*****::::**: 
NP_731850.2         LKRILVLMKSTHTFLVLGALRLLRKIIALKDEFYNRHIVKCNLFAPVVDAFIRNNGRYNL 
AAH72409.1          LRRVLVLMASKHAFLALCALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNL 
pB27_A-294          LRRVLVLMASKHAFLALCALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNL 
NP_001271209.1      LRRVLVLMASKHAFLALCALRFKRKIIGLKDEFYNRYIMKSFLFEPVVKAFLNNGSRYNL  
          *:*:**** *.*:**.* ***: ****.********:*:*. ** ***.**:.*..**** 
NP_731850.2         LESAILELFEFIKLEDIRTLCVYFVENFSKIFDEIEYVQTFKYLKNRYDQYQDRLKDRDK 
AAH72409.1          MNSAIIEMFEFIRVEDIKSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDN--- 
pB27_A-294          MNSAIIEMFEFIRVEDIKSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDN--- 
NP_001271209.1      MNSAIIEMFEFIRVEDIKSLTAHVIENYWKALEDVDYVQTFKGLKLRFEQQRERQDN---  
          ::***:*:****::***::* .:.:**: * :::::****** ** *::* ::* .:      
NP_731850.2         MENRTDGGLPIIRSGGRFRRDQRQMEEEEEMWFNEEDDFTEEIDTYNNVMKSVSEKNG-- 
AAH72409.1          ---PKLDSMRSILRNHRYRRDARTLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIM 
pB27_A-294          ---PKLDSMRSILRNHRYRRDARTLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIM 
NP_001271209.1      ---PKLDSMRSILRNHRYRRDARTLEDEEEMWFNTDEDDMEDGEAVVSPSDKTKNDDDIM 
     . ..:  *  . *:*** * :*:******* ::*  *: ::  .  ....:.:. 
NP_731850.2         ------------------------------------------------------------ 
AAH72409.1          DPISKFMERKKLKESEEKEVLLKTNLSGRQSPSFKLSLSSGTKTNLTSQSSTTNLPGSPG 
pB27_A-294          DPISKFMERKKLKESEEKEVLLKTNLSGRQSPSFKLSLSSGTKTNLTSQSSTTNLPGSPG 
NP_001271209.1      DPISKFMERKKLKESEEKEVLLKTNLSGRQSPSFKLSLSSGTKTNLTSQSSTTNLPGSPG                                                                                    
 
NP_731850.2         ------------------------------------------------------------ 
AAH72409.1          SPGSPGSPGSPGSVPKNTSQTAAITTKGGLVGLVDYPDDDEDDDEDEDKEDTLPLSKKAK 
pB27_A-294          SPGSPGSPGSPGSVPKNTSQTAAITTKGGLVGLVDYPDDDEDDDEDEDK----------- 
NP_001271209.1      SPGSPGSPGSPGSVPKNTSQTAAITTKGGLVGLVDYPDDDEDDDEDEDKEDTLPLSKKAK                                                                                    
 
NP_731850.2         ---  
AAH72409.1          FDS  
pB27_A-294          ---  
NP_001271209.1      FDS                       
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3.1.2 Expression of SMEK1 and PP4c in human A549 pneumocytes 
The expression of SMEK1 in non-infected A549 lung pneumocytic epithelial cells needed to be 
confirmed. The cell line used for the work on IAV was an immortalised A549 lung epithelial cell. It was 
noted on the Gene Cards website that A549 expresses SMEK1 (http://www.genecards.org/), however 
confirmation of expression was needed before continuing with the project. Human cervix epithelial cells 
(HeLa) cells were included as a positive control. Soluble and insoluble fractions of cell lysates were 
collected from non-infected A549 and HeLa cells (as a positive control) and analysed via dot blot with 
specific antibodies. A dot blot was performed as shown in Figure 9. By adding crude cell lysates directly 
to the PVDF membrane, PP4c and SMEK1 expression was detected in A549 and HeLa cells.  
 
Figure 9. Analysis of detection of SMEK1 and PP4c in A549 and HeLa cell lines by dot blot for 
optimisation of SMEK1 and PP4c detection after 10 minutes’ exposure. Antibodies used were rabbit anti-
SMEK1 (abcam) and anti-PP4c antibody (Bethyl Labs) in HeLa insoluble fractions (IF) and soluble 
fractions (SF) and A549 SF and IF). There is clear expression of SMEK1 and PP4c protein in SF of both 
A549 and HeLa cells. This confirms SMEK1 expression detection with rabbit anti-SMEK1 antibody 
(abcam). (Exposure time and full membranes can be found in Appendix 9 i). 
The results from the dot blot show that in non-infected cells PP4c is expressed in both A549 and HeLa 
cells. There is a higher presence of PP4c in the cytosol and solubilised membranes (the soluble fraction) 
than in nuclear debris, insoluble membranes and cytoskeleton components (insoluble fraction). There is 
PP4c expression at higher levels in the soluble fraction than in the insoluble fraction. There is also a 
higher level of SMEK1 expression in the soluble fraction rather than the insoluble fraction. There is more 
SMEK1 expression in the insoluble fraction in comparison to PP4c. SMEK1 is primarily found in the 
nucleus, as seen in Figures 13, 14 and 15. PP4c, however, is expressed more ubiquitously.  
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Figure 10. Expression of SMEK1 and PP4c using whole cell lysis technique (Chapter 2.7 Table 2). 10µl 
of cell lysates was loaded for this SDS-PAGE gel run. There is a higher level of expression of SMEK1 in 
HeLa cells compared to A549 lung epithelial cells. There are bands displaying PP4c in similar amounts 
in both HeLa and A549. (Exposure time and full membranes can be found in Appendix 10 i, ii and iii). 
Non-infected A549 and HeLa whole cell lysates were run on an SDS-PAGE gel and analysed by 
western blot to confirm the detection of SMEK1 and PP4c. Figure 10 shows PP4c expression in both 
A549 and HeLa cells. GAPDH, a house-keeping protein, was used as a loading control (upper panel). 
There is a faint band for SMEK1 in A549, but bands for HeLa. This is could be due to lower SMEK1 
expression in A549 cells.  
There was also clear presence of double bands for SMEK1. These showed the presence of both 
phosphorylated forms of SMEK1, as described by Lipinzki et al. (2015), as the higher molecular weight 
band on western blot analysis of the SDS-PAGE gel. The presence of two bands indicated the 
expression of both phosphorylated and dephosphorylated forms of SMEK1. This denoted the presence 
of PP4c in cells, as it is known to dephosphorylate SMEK1 in a 1:1 ratio. This suggests 
dephosphorylation of SMEK1 by PP4c (Lipinszki et al., 2015). 
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3.1.2.3 Effect of denaturation and reduction of disulphide bonds on detection of SMEK1 and 
PP4c 
It was necessary to study the forms of SMEK1 and PP4c detected in different conditions through SDS-
PAGE and western blot analysis. Using whole cell lysis technique (described in Chapter 2.7), the 
conditions of the lysates were altered to enable optimal detection. It was then possible to determine the 
effect of heat-denaturation and reduction of disulphide bonds on detection of monomers and 
PP4c/SMEK1 complexes. Lysates were prepared without reducing agents in the lysis buffer. Samples 
were then subjected to different conditions.  
 
 
Figure 11. Western blot analysis of SDS-PAGE gel for differing treatments of A549 and HeLa lysate 
treatments. ‘None’ refers to no treatment except lysis buffer); ‘Heated’ indicates that samples were 
heated to 100oC for 5 minutes before loading; ‘Reduced’ samples were treated with B-mercaptoethanol 
to reduce disulphide bonds; ‘Both’ indicates samples were subjected to both heating and reducing 
treatments. (Exposure time and full membranes can be found in Appendix 11 i, ii and iii). 
Figure 11 shows further analysis of SMEK1 and PP4c in A549 cells. There was no noticeable difference 
in SMEK1 levels across the differing treatments of A549 cell lysates. Figure 11 also confirmed the 
double bands shown in Figure 10; here this was also accompanied by a smear at a higher molecular 
weight. The larger of the double bands was due to the presence of both phosphorylated and non-
phosphorylated forms of SMEK1 (Lipinszki et al., 2015).  
There appeared to be some reduction in signal in HeLa cell lysates when no treatment was performed 
on lysates, however this was not the case for A549 cells without treatment. This was most likely due to 
the difference in protein structure. Without heating or reducing treatments the tertiary structure of these 
proteins may have prevented antibody binding site exposure.  
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The presence of higher molecular weight bands in the SMEK1 labelled lysates could mean identification 
of high weight molecular complexes containing SMEK1 and/or PP4c in absence of denaturation or 
disulphide bonds reduction. 
 
3.1.3 Effect of influenza A virus infection on SMEK1 and PP4c expression 
PP4c and SMEK1 expression patterns were analysed following IAV A/WSN/33 infection of A549 cells 
over varying time points. The time points were chosen to enable visualisation of protein expression after 
viral binding to cellular membrane, post viral entry and after cycles of replication. It was hoped that IAV 
infection would influence the pattern of expression of SMEK1 and PP4c. This was described by both 
western blot and immunofluorescence.  
3.1.3.1 Infection down-regulates SMEK1 expression in A549 cells  
Lysates were taken using the fractionation lysis technique; the soluble fraction ran on SDS-PAGE gel.  
Figure 12. Western blot analysis of A549 cells infected at an MOI of 3 for 24 hours. Shown here are 
western blots for GAPDH (loading control), M1 (viral protein), SMEK1 (protein of interest). Antibodies 
used were: Mouse anti-GAPDH 1:2000 (Abcam), Mouse anti-M1 (1;1000), Rabbit anti-SMEK1 (1:2000) 
(Abcam). (Exposure time and full membranes can be found in Appendix 12 i, ii and iii).  
Cell lysates were collected using fractionation lysis buffer after fixing the coverslips in PFA. Shown in 
Figure 12 is an increase in M1 as infection continued (from 3H to 24H). There was a drop in SMEK1 
expression at 0H (where IAV binds to the cellular membrane, but does not enter the cell), and an 
expression recovered as infection continued to 24H. This also coincided with an increase in M1 from 0H 
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to 24H. This suggested that as infection continued and viral protein load increased with viral replication, 
there was also an increase in SMEK1 expression. 
No double bonds for SMEK1 indicated that there was either a large amount of PP4c present, or a lack of 
PP4c. This could also be due to the different lysis buffer used for this technique. Double bands for 
SMEK1 indicated that there were both phosphorylated and dephosphorylated forms of SMEK1. There 
was a faint double band for SMEK1 for HeLa cell sample; this is most likely due to mid-transfer 
movement of the gel/membrane sandwich. However, it could indicate both phosphorylated forms of 
SMEK1 were present in only this sample. Further analysis is required to clarify this.  
3.1.3.2 Immunofluorence Assay of Infected A549 cells 
A549 lung epithelial cells were infected at varying multiplicities of infection (MOI) for varying time points 
to ascertain the effect of ongoing infection. Using immunofluorescence, it was possible to observe the 





Figure 13. IFA analysis of MOI 3 infection of A549 lung epithelial cells at varying time points post-
infection. Shown here is SMEK1 expression and PP4c expression at varying infection time points at MOI 
3. DAPI staining of the nucleus is shown on the left, M2 stained with mouse anti-M2 primary antibody 
and Texas Red secondary antibody, SMEK1 stained with rabbit anti-pp4r3α (SMEK1) primary anti-body 
and anti-rabbit Alexa 488 secondary antibody, PP4c stained with Rabbit anti-PP4c and anti-rabbit Alexa 
488 secondary antibody. Corrected total cell fluorescence was measured and plotted in the two bottom 
panels. Error bars show standard deviation of average corrected total cell fluorescence (CTCF).  
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The samples analysed by western blot (Figure 12) were studied by fluorescence microscopy (Figure 13). 
Little to no signal for PP4c and SMEK1 was found in non-infected (NI) and after 6 hours (6H) of 
infection. As this was seen in both SMEK1 and PP4c samples it is possible that this is due to very low 
relative expression levels of PP4c and SMEK1 in non-infected samples.  
Interestingly, a sharp increase in PP4c expression was observed at 10 hours’ post-infection and a 
further increase at 24 hours’ post-infection (Figure 13). The A/WSN/33 lifecycle is approximately 6-8 
hours. These results suggest that after one cycle of infection (at the 10-hour time point) infection caused 
an increase in expression of PP4c across the cell. There was a larger increase in expression at 24 
hours, following approximately 3 cycles of infection. The expression pattern of PP4c at 10H is mainly 
cytosolic, however at 24H it appears that there is concentration of PP4c in the nucleus. This result 
requires confirmation, as a later IFA (Figure 14 and 15) did not show such a clear increase in 
expression. This may be due to differing MOI, or a different mounting medium being used (Vectashield 
vs Dabco), which allowed for better immunofluorescence and detection of PP4c expression in NI cells.  
As shown in Figure 13, SMEK1 expression started to increase at 6 hours’ post-infection. There was M2 
expression, which corresponded with increase in SMEK1 expression. At 10 hours, post-infection there 
was a large increase in SMEK1 expression. Most of the SMEK1 was found in the nucleus 
(corresponding with DAPI staining), with some in the cytosol. At 24 hours, the level of expression of 
SMEK1 in the nucleus decreased, whilst there appeared to be an increase in SMEK1 in the cytosol. This 
suggested SMEK1 had translocated out of the nucleus. This would explain the decrease in corrected 
total cell fluorescence, as this measured overall cell fluorescence. Therefore, lower concentrated 
expression would appear to have reduced average expression. 
The error bars on the bottom right panel in Figure 13 show that as PP4c expression levels increase so 
does the error. This coincides with an increase in error as M2 levels increase. This shows the variety of 
increase, most likely dependent on infection efficacy. Expression levels are dependent on efficacy of 
infection of all cells. If all cells are not infected, then this will skew results. This is also the case for M2 
expression in the bottom left panel. This shows the variety in levels of infection. 
This experiment was repeated, using a higher MOI of 10 (Figure 14). Cells were stained for M1 rather 
than M2 structural protein due to its higher prevalence at shorter time points; it therefore served as a 
better positive control of infection. Staining with M1 rather than M2 meant it would not be possible to see 
any co-localisation between M2 and SMEK1. 
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Figure 14. IFA analysis of MOI 10 infection of A549 lung epithelial cells at varying time points post-
infection. Shown is PP4c and SMEK-1 expression NI (non-infected), 0H (viral binding only), 4H (4 hours 
post-infection), 8H (8 hours post-infection,) at MOI 10. DAPI staining of the nucleus is on the left. M1 
was stained as an infection positive control with mouse anti-M1 primary antibody and Texas Red 
secondary antibody. PP4c was stained in the right-hand panels with rabbit anti-PP4c primary antibody 
and anti-rabbit Alexa 488 secondary antibody. SMEK1 was stained with rabbit anti-PP4R3α (SMEK1) 
primary antibody and anti-rabbit Alexa 488 secondary antibody. Corrected total cell fluorescence was 
measured and plotted in the two bottom panels. Error bars show standard deviation of average 
corrected total cell flourescence (CTCF). 
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In Figure 14 translocation of PP4c from the nucleus to the cytosol can be seen. The staining of PP4c 
from NI to 0H decreases, then increases after 8H but with similar distribution to M1. It was interesting to 
see detection of M1 from viral particles added to cells at 0H. This showed that an MOI of 10 had ensured 
that all cells were infected and showed the high ratio of viral particles on cells; this confirmed binding 
had been effective. At 0H time point the virus could bind to the cells, but not enter them. Binding of IAV 
appeared to influence PP4c expression within cells. This could be due to IAV triggering a cascade of 
events by binding to PRRs at the cell membrane (Yoo et al., 2013).  
At 4H and 8H post-infection, the pattern of expression of PP4c had changed. The expression pattern 
was like that of M1; this could be seen at higher levels in the nucleus at 4H. The expression of PP4c in 
NI cells was much more distinctive; there was defined expression in the cytosol and less expression in 
the nucleus. Following infection this changed. PP4c expression became more nucleic; it was possible to 
identify where the nucleus was by looking at PP4c expression. Here we can clearly see nuclear and 
cytosolic localisation of PP4c.  
SMEK1 expression followed a similar pattern of increase as PP4c during IAV infection. The levels to 
which they increased were not as dramatic as PP4c. There was little translocation of SMEK1 from the 
nucleus to the cytosol. To quantify the degree of translocation would require further analysis. There was, 
however, less SMEK1 expression in the cytosol in NI cells when compared to 8H of infection. This did 
not seem to be as significant as that seen in PP4c cells.  
It appeared there was some similar distribution of M1 and PP4c post-infection. However, this would 
need to be analysed by confocal microscopy to confirm and give better resolution. Similar distribution 
patterns are likely to have been due to leakage between channels due to the lack of similar expression 
patterns of M1 in the SMEK1 samples. There were also similar artefacts found in both samples. This 
experiment will need to be repeated to confirm these results. If there is indeed co-localisation between 
M1 and PP4c, this presents a novel interaction that may have further implications for IAV infection. 
In this experiment, influence of infection on SMEK1 expression was only detected after one cycle of 
infection was completed. However, for the effect on PP4c to be noticed, only one cycle of IAV infection 
was required to see a difference in expression patterns. 
The error bars (bottom left panel) for M1 are larger than SMEK1; this represents the variety in levels of 
infection. Cells allowing better viral replication will show higher expression levels of M1. The error bars 
for PP4c (bottom right panel) are much larger, again representing much larger variety in expression, 
especially in NI cells.  
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Figure 15. IFA analysis of MOI 0.3 infection of A549 lung epithelial cells at varying time points post-
infection. Shown are viral protein M2 and human protein PP4c and SMEK1 expression across 4 time 
points: non-infected cells (NI), viral binding (0H), 12 hours’ post-infection (12H) and 24 hours’ post-
infection (24H). Corrected total cell fluorescence was measured and plotted in the two bottom panels 
Error bars show standard deviation of average corrected total cell fluorescence (CTCF). 
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To investigate the effect of infection using a low MOI, a similar IFA was repeated using an MOI of 0.3. 
As expected, M2 signal could only be efficiently detected after several rounds of infection at 24H (Figure 
15). This experiment cells confirmed an increase in PP4c expression at 24 hours’ post-infection, after a 
decrease following viral binding to cell surface. At 24H of infection PP4c expression levels were slightly 
higher than NI and much higher than at 0H. This showed an elevated level of PP4c in cells expressing 
more of the viral protein M2, even at a lower MOI than shown before (MOI 0.3 as opposed to MOI 3 
shown in Figure 10). The advantage of this lower MOI 0.3 for this experiment was to show an increase in 
PP4c correlated to the level of viral proteins within infected cells. 
The levels of SMEK1 expression were very interesting. Following IAV binding at 0H SMEK1 and PP4c 
levels decreased. After 12H of infection SMEK1 levels increased, but PP4c levels did not. This followed 
an increase in M2 expression levels from 12H to 24H. At 24H post-infection, SMEK1 expression levels 
decreased. The increase in M2 expression levels was not as dramatic as that seen in the PP4c sample 
and could be partially responsible for the decrease in SMEK1. This could be because the coverslip with 
cells for this sample did not experience a similar level of infection of IAV. 
Figure 15 confirmed western blot analysis (Figure 12) of SMEK1 expression patterns; following viral 
binging to cell surface, SMEK1 levels are down-regulated. As infection continues SMEK1 levels 
increase. However, in Figure 15 SMEK1 levels decreased again at 24H. PP4c expression patterns were 
also confirmed by IFA in Figures 13 and 15; non-infected expression is mainly cytosolic, following 24H of 
infection, PP4c is found in both the cytosol and the nucleus. The expression increase of PP4c found at 
24H of infection was found to be relative to the MOI of infection. A higher MOI caused a more dramatic 
increase in PP4c expression. This suggests that the increase is due to viral infection. 
3.1.4 Co-Immunoprecipitation of SMEK1 and M2 in infected A549 cells 
An in vivo interaction needed to be proved. IAV infected A549 cell lysates were probed for SMEK1 and 
M2 binding. Cell lysates were incubated with IgG antibodies anti-M2, anti-PP4R3α (SMEK1), anti-
AnnexinA6, anti-PP4c and anti-NFkB. Annexin A6 and NFkB were included as controls. PP4c is known 
to bind to SMEK1 as it forms a complex. NFkB and Annexin A6 were used as control rabbit antibodies. 
Complexes were recovered by adsorption on protein A/G-sepharose beads and analysis by SDS-page 
gel electrophoresis and western blot. This allowed confirmation of the results of the yeast two-hybrid 




Figure 16. Western Blot analysis following SDS-PAGE gel co-immunoprecipitation of 24 hours infected 
A549 lung epithelial cell lysates. The lanes indicated are (left – right): A549 cell lysates (A549); flow 
through from pre-clearing of infected A549 cell lysates (FT); then samples that were co-
immunoprecipitated (IP) by incubation with mouse anti-M2 (M2); rabbit anti-PP4c (PP4c); rabbit anti-
SMEK1 (SMEK1); rabbit anti-Annexin A6 (A6); and rabbit anti-NFkB (NFkB) antibodies. Membranes 
were then immunoblotted with anti-M2 (A and B), anti-SMEK1 (C and D), anti-NFkB (E), and anti-PP4c 
(F). (Full membranes can be found in Appendix 16 i, ii, iii and iiii).  
M2 tetramer co-immunoprecipitates with PP4c, SMEK1, Annexin A6 and NFkB    
Immunoblot with anti-M2 antibody shows the proteins by which M2 is co-immunoprecipitated with, there 
are bands in all samples for M2 tetramer and dimer (Figure 16A and B). There are stronger bands for 
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the M2 tetramer, this shows poor denaturation of the M2 complex whilst processing samples and a more 
efficient co-immunoprecipitation of the tetramer. Interestingly all proteins tested could immunoprecipitate 
M2 tetramers. This suggests formation of multimolecular complexes between IAV M2 and PP4c, 
SMEK1, Annexin A6 and NFkB. 
Differential interaction of SMEK1 and phosphorylated SMEK1 with M2, PP4c, Annexin A6 and 
NFkB 
Immunoblot with anti-SMEK1 antibody shows the proteins SMEK1 is co-immunoprecipitated with (Figure 
16C).  There was a band at 95 kDa for SMEK1 in the sample incubated (16D) with mouse anti-M2 
antibody, which indicates interaction. After longer exposure (Figure 16D), this band is clearer and shows 
dephosphorylated SMEK1 co-immunoprecipitates with M2. 
This result indicates that M2 only interacts with de-phosphorylated SMEK1. This confirms an interaction 
between SMEK1 and M2 in A549 cells. Previous work by Ma et al. (2012) required up-regulation of host 
protein expression to get clearly defined bands for co-immunoprecipitation. Therefore, it may be 
necessary to repeat this following upregulation of SMEK1 for clearer results. 
It was interesting to note that Annexin A6 only interacts with the phosphorylated form of SMEK1, while 
PP4c and NFkB bind to both phosphorylated and non-phosphorylated SMEK1. This result further 
confirms the formation of multimolecular complexes and indicates that SMEK1 and phosphorylated 
SMEK1 are differentially involved in these complexes. 
NFkB interacts with SMEK1 and Annexin A6; PP4c interacts with the Annexin A6 and NFkB  
Interestingly, NFkB was immunoprecipitated with SMEK1 and Annexin A6 (Figure 16E). A high 
molecular weight band could be detected with the anti-NFkB p65 antibody. It was reasoned that these 
bands correspond to the complexes involving the p65 subunit of NFkB, most likely p65/p50 or p52 and 
p65/p50 or p52 and IkB. 
Weak bands could be observed for PP4c in lanes corresponding to immunoprecipitation of SMEK1, 
Annexin A6 and NFkB. These data not only confirm the interaction between M2 and SMEK1 (non-
phosphorylated form) in infected cells, but also present novel interactions between the PP4 complex, 
Annexin A6 and NFkB.  
To ensure that the detection of SMEK1 in M2 co-immunoprecipitated samples was not due to leakage 
from neighbouring lanes, the samples were run again on a SDS-PAGE gel with lanes left empty between 
each sample (Figure 17). 
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Figure 17. Western blot analysis following SDS-PAGE gel of co-immunoprecipitation. The lanes 
indicated are (left – right): Panel A: infected A549 cell lysates (A549); rabbit anti-SMEK1 (SMEK1); 
rabbit anti-PP4c (PP4c); rabbit anti-NFkB (NFkB) antibodies. Immunoblotted with mouse anti-M2 
monoclonal antibody. Panel B: infected A549 cell lysates (A549); incubated with mouse anti-M2 (M2); 
and mouse anti-Annexin A6 (A6). Immunoblotted with rabbit anti-SMEK1 monoclonal antibody. 
(Exposure time and full membranes can be found in Appendix 17 i and ii). 
 56 
Figure 17 shows a rerun of the samples in Figure 16. Gaps were left between samples to ensure that 
there was no leakage of samples between lanes. There is co-immunoprecipitation of M2 dimer in 
SMEK1, PP4c and NFkB precipitated samples at 34 kDa (Figure 17A). This confirmed there was an 
interaction in infected A549 cells between SMEK1 and M2. This confirms the results shown in Figure 
16B. As there is a band found at 34kDa in the A549 lysate sample (which contains no antibodies), this 
precludes to poor denaturisation of the samples. It is expected that the monomer of M2 would be 
separated even if denaturation had worked efficiently. The monomer is expected to be found at 17 kDa, 
therefore a dimer would be expected at around 34 kDa. Therefore, it is possible that instead of 
separating M2 as a monomer, a dimer has been separated in the gel. This would confirm the interaction 
between M2 and SMEK1, whilst also identifying an interaction between M2 and PP4c and NFkB. To 
confirm this, thorough denaturation of samples would be required.  
Figure 17B also confirms the co-immunoprecipitation between SMEK1 and Annexin A6. This presents a 
novel interaction between Annexin A6 and SMEK1. Further research is required to confirm and describe 





This work is the first to describe an interaction between influenza A virus M2 and human SMEK1 in 
infected lung epithelial cells. 
The overlap between the M2 binding domain and ARM repeat domain (shown in Figure 7), may 
influence the ability of SMEK1 to bind to PP4 in infected cells. The ARM repeat was shown to be 
important for PP4 recognition for SMEK1 binding. This requires further investigation. 
There is some evidence of SMEK1 translocation from the nucleus to the cytosol (Figures 13, 14, 15). 
This requires further quantification. If this is proven it could have implications for the effect on IAV 
infection on expression patterns of SMEK1 after infections. Measurements of concentration of SMEK1 in 
the nucleus and in the cytosol would need to be taken before and after infection. Western blot analysis 
of nuclear fractionation of infected A549 cell lysates could confirm the translocation observed.  
Western blot results showed that there was an initial decrease in SMEK1 expression, but this returned to 
normal levels as infection continued (Figure 12).  Repeats are required to confirm these results. Western 
blot and immunofluorescence analysis of shorter infection time points could help explain and describe 
the expression profile of SMEK1 post infection.  
The bands for M2 dimer and tetramers in the anti-SMEK1 antibody immunoprecipitated samples showed 
an interaction between SMEK1 and M2. The probability of this reaction being transient increased with 
the observation that SMEK1 was not co-immunoprecipitated as well with anti-M2 antibody incubated 
samples. The co-immunoprecipitation of SMEK1 by M2 gave signs of an interaction with the non-
phosphorylated form of SMEK1. To confirm the presence of an interaction between M2 and SMEK1, it 
may be necessary to upregulate expression of SMEK1 in A549 cells. Subsequent co-
immunoprecipitation would give better and clearer results; in theory, stronger bands would be produced 
after an increase in SMEK1 expression. From the same Yeast two-hybrid screen, Ma et al (2012) used 
this method of upregulation of human cellular factors to confirm co-immunoprecipitation with viral 
proteins.  
Through co-immunoprecipitation a potential complex was identified that has not previously been 
described (Figure 18). Here we have hypothesised that the interactions identified may form part of a 
complex. It is known that the PP4 complex can interact with p65 subunit of the NFkB complex, and that 
complex can interact with Annexin A6. The interaction between SMEK1 and p65 subunit has identified 
how the PP4 and NFkB complexes interact. As it was shown that only the phosphorylated form of 
SMEK1 interacts with M2, NFkB and Annexin A6, it may be that SMEK1 interacts with these factors in 
the absence of PP4c. The dephosphorylated form of SMEK1 was identified to interact with NFkB, 
Annexin A6 and PP4c, therefore it may be that when PP4c is in complex with SMEK1, PP4c can 




Figure 18. Schematic diagram of the proposed interactions as found by this study. Shown are the 
potential forms in which the cellular factors investigated could interact. Annexin A6 (A6) is shown to 
interact with the CT tail of transmembrane M2 protein. The proposed interaction between 
dephosphorylated SMEK1 and the CT tail of transmembrane M2 in complex with PP4c, the NFkB 
complex (IkB, p65 and p50/p52), and potentially Annexin A6. The phosphorylated form of SMEK1 is 
shown to interact with PP4c, Annexin A6, and the NFkB complex.  Red arrows signify potential 
dephosphorylation by PP4c. 
There was an impact of infection on the catalytic unit (PP4c) of the PP4 complex that SMEK1 forms. An 
increase in PP4c expression has been confirmed in infected A549 cells. The accumulation of PP4c may 
have an advantageous effect for the host. Increase in PP4c causes an increase in dephosphorylation of 
TBK1 at Ser-172, leading to TBK1 inhibition (Zhan et al., 2015). A decrease in activated TBK1 would 
cause a decrease of phosphorylation of IRF3 and IRF7, this could decrease type-1 IFN and IFN-
stimulated induction. This would then lead to a decreased inhibition of viral replication and inhibited 
clearance of infected cells (Figure 5). Therefore, this increase in PP4c is a negative host cell response to 
viral infection.  
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The increase in PP4 production post-IAV infection (Figure 13) needs to be confirmed; the same 
expression pattern was not seen at a lower MOI (Figure 15). If this increase were to be confirmed, it 
would present implications for the understanding of cellular reactions to IAV infection. PP4 is known to 
be involved in IFN signalling (Zhan et al., 2015). 
The implications of an increase in PP4 post-infection could have one of two effects. This could be due 
an accumulation of PP4, whereby the function is blocked by viral blockage of the cell cycle. It was 
described by Fan et al. (2017) that IAV halts the cell cycle. Due to PP4c role in the cell cycle, it is 
possible that IAV-induced cell cycle blockage has led to an accumulation of PP4c during infection. 
There is also the possibility that the interaction between M2 and SMEK1 could be a cellular response to 
viral infection. Post-infection host cells increase PP4 production as a part of immune response to 
increase IFN expression and clear IAV infected cells by inducing an anti-viral state using IFN stimulated 
genes. 
3.2.2 Future Directions 
Following confirmation of the interaction, the reasons for M2 and SMEK1 binding would be investigated 
to discover the physiological relevance of this interaction. Interactions between SMEK1 and NFkB as 
well as SMEK1 and Annexin A6 were identified through this co-immunoprecipitation assay. SMEK1 has 
been found to down-regulate NFkB (Dong et al., 2012; Byun et al., 2012). However, PP4 was found to 
activate NFkB (Martin-Granados et al., 2008; Yeh et al., 2004). Further clarification of the roles of the 
subunits in NFkB regulation is required. It is possible SMEK1’s role is independent of the PP4 complex, 
the role of SMEK1 and PP4 require further investigation. This co-immunoprecipitation has presented 
new interactions, not previously described in literature; and confirmed those already known. These 
interactions should be confirmed, presenting new projects to understand SMEK1 interactions in human 
cells.  
The cause for the PP4c increase seen at 24 hours’ post-infection should be investigated. This could be 
done by testing the production of cytokines related to IFN response, to viral infection, at varying time 
points by qPCR. This would clarify the implications of the increase in PP4 on viral immune response. A 
change in immunocytokine production could produce a very interesting and novel piece of work to clarify 
the host response to viral infection. 
The effect of this bond on viral particle production could be ascertained by down-regulating PP4 
expression in A549 cells. It would be possible to determine whether PP4 is a restricting factor for IAV 
infection. Then test the effects on viral pathogenesis using siRNA down-regulation of PP4 expression in 
A549 lung epithelial cell line. This would be done following testing by western blot to confirm down-
regulation of PP4 expression. Following this a test for the effectiveness of IAV infection in both A549 and 
A549 PP4c-downregulated cells should be performed using several methods.  
- TCID50 would allow an assessment of the viral pathogenesis on these different cell lines. This 
would allow the calculation of the effect of PP4c-downregulation on IAV.  
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- Western blot and flow cytometry can confirm the levels of viral proteins in both infected cell lines.  
- IFA could be used to visualize changes following PP4c-downregulation to clarify whether PP4c 
depletion influences viral progeny. IFA allows visualisation of the location of proteins within the cell. 
Therefore, any differences in viral protein localisation could be found easily. 
It would then be necessary to elucidate the effects on other systems within the cell following IAV 
infection and subsequent binding to SMEK1. Protein phosphatase PP4 has many functions in many 
different cellular processes. There is a strongly defined role of PP4c in cell cycle and microtubule 
organization, as well as a role in apoptosis. This could be affected by the up-regulation in PP4 found at 
24 hours’ post-infection. Therefore, it would be prudent to see what effect increased PP4 has on these 
functions post-infection.  
It may be possible to discover more about the function of SMEK1 and its role in the cell through its 
relationship with M2. By testing for the effects of an increase of PP4 on the functions of PP4, it may be 
possible to find new functions previously undiscovered. It is conceivable that a novel role for PP4 may 
be found in the host viral immune response.  
3.2.2.1 Substrates 
By analyzing the effect of this interaction, it is important to investigate the effect of infection on the 
substrates of PP4c. TBK1 is dephosphorylated by PP4c (Zhan et al., 2015); an accumulation of PP4c 
post infection could has a negative effect on the signalling pathway for IFN-1 production. This would be 
beneficial for IAV as IFN-1 is essential for viral clearance.  
The role of PP4 in the cell cycle is much better characterised than its role in apoptosis. p27 is a 
substrate of PP4c, p27 is a CD1 inhibitor. PP4 allows progression through the cell cycle by activating 
p27 and inhibiting CD1 and CDK4 (Dong et al., 2012). An increase in PP4c could influence the 
progression of cells through G2. However, it is known that infection blocks progression of the cell cycle 
(Fan et al., 2017). There is an interaction between PP4 and CDK1, involved in microtubule organisation. 
PP4 regulates CDK1 negatively; this prevents unscheduled activation of CDK1 throughout the cell cycle. 
It is thought that due to its dominance over CDK1, PP4 could be a checkpoint protein. NDEL1 (a 
substrate of CDK1) recruits katanin p60, which is heavily involved in microtubule dynamics and 
remodelling (Toyo-oka et al., 2008). An increase of PP4c following infection could have a negative effect 
on CDK1. This could lead to cell cycle arrest 
It is known that PP4 interacts with RhoGTPases. The regulation of RhoGTPases by PP4-R2-R3 (R3 
being SMEK1) complex may co-ordinate centrosome maturation and cell migration (Martin-Granados et 
al., 2008). It may be hard to quantify an effect of the up-regulation of PP4c on these processes. 
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Table 4 of clones identified through the yeast two-hybrid screen. Shown are the theoretical fragment 
sequences based on the 3” and 5” sequences identified through the screen. The first two clones 
PLA_RP_hgx1492v1_pB27_A-180 and PLA_RP_hgx1492v1_pB27_A-67 had only 3” and 5” sequences 
respectively. Therefore shown in this table is the 3” sequence for clone PLA_RP_hgx1492v1_pB27_A-
180 shows the 3” sequence and clone PLA_RP_hgx1492v1_pB27_A-67 shows 5” sequence. During the 
yeast two-hybrid screen analysis these sequences were used for alignment as fragment theoretical 
sequences were not provided.  
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B Full western blot membrane images 
Figure 9 (i) 
 
Full scanned X-ray film for dot blot analysis of SMEK1 and PP4c expression in A549 and HeLa cells. 
Figure 10 (i) 
 
Full scanned X-ray film for western blot analysis of GAPDH labelling of A549 and HeLa samples, 









Full scanned X-ray film for western blot analysis of PP4c labelling of A549 and HeLa samples, after 10 
minutes of exposure. 
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Figure 10 (iii) 
 
Full scanned X-ray film for western blot analysis of SMEK1 labelling of A549 and HeLa samples, 




Full scanned X-ray film for western blot analysis of GAPDH labelling of A549 and HeLa samples after 10 






Full scanned X-ray film for western blot analysis of PP4c labelling of A549 and HeLa samples, after 5 




Full scanned X-ray film for western blot analysis of SMEK1 labelling of A549 and HeLa samples, 
following 1 minute of exposure. 
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Figure 12 (i) 
 
Full scanned X-ray film for western blot analysis of GAPDH labelling of A549, HeLa, and infected A549 
samples (NI, 0H, 3H, 6H, 12H, 24H) after 10 seconds of exposure. 
 
Figure 12 (ii) 
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Full scanned X-ray film for western blot analysis of M1 labelling of infected A549 samples (24H, 12H, 
6H, 3H, 0H, NI), HeLa and A549, after 1 minute of exposure. 
Figure 12 (iii) 
 
Full scanned X-ray film for western blot analysis of SMEK1 labelling of A549, HeLa and infected A549 
samples (NI, 0H, 3H, 6H, 12H, 24H), following 10 minutes of exposure. 
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Figure 16 (i) 
 
Full scanned X-ray film for western blot analysis of SMEK1 staining of A549 lysate, Flow through, M2, 




Figure 16 (ii) 
 
Full scanned X-ray film for western blot analysis of NFkB staining of A549 lysate, Flow through, M2, 
PP4c, SMEK1, Annexin A6 and NFkB incubated co-immunoprecipitation samples after 30 seconds of 
exposure. 
 
Figure 16 (iii) 
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Full scanned X-ray film for western blot analysis of PP4c staining of A549 lysate, Flow through, M2, 
PP4c, SMEK1, Annexin A6 and NFkB incubated co-immunoprecipitation samples after 30 seconds of 
exposure. 
Figure 16 (iiii) 
 
Full scanned X-ray film for western blot analysis of M2 staining of A549 lysate, Flow through, M2, PP4c, 





Full scanned X-ray film for western blot analysis of M2 labelling of A549 lysate, SMEK1, PP4c and NFkB 
incubated samples after 10 minutes of exposure. 
Figure 17(ii) 
 
Full scanned X-ray film for western blot analysis of SMEK1 labelling of A549 lysate, M2 and Annexin A6 
incubated samples after 10 minutes of exposure. 
